| Year |
Citation |
Score |
| 2023 |
Marzulli M, Hall BL, Zhang M, Goins WF, Cohen JB, Glorioso JC. Novel mutations in U24 and gH rescue efficient infection of an HSV vector retargeted to TrkA. Molecular Therapy. Methods & Clinical Development. 30: 208-220. PMID 37519407 DOI: 10.1016/j.omtm.2023.06.012 |
0.377 |
|
| 2022 |
Kuroda S, Miyagawa Y, Sukegawa M, Tomono T, Yamamoto M, Adachi K, Verlengia G, Goins WF, Cohen JB, Glorioso JC, Okada T. Evaluation of parameters for efficient purification and long-term storage of herpes simplex virus-based vectors. Molecular Therapy. Methods & Clinical Development. 26: 132-143. PMID 35795777 DOI: 10.1016/j.omtm.2022.06.007 |
0.355 |
|
| 2022 |
Otani Y, Yoo JY, Lewis CT, Chao S, Swanner J, Shimizu T, Kang JM, Murphy SA, Rivera-Caraballo K, Hong B, Glorioso JC, Nakashima H, Lawler SE, Banasavadi-Siddegowda Y, Heiss JD, et al. NOTCH induced MDSC recruitment after oHSV virotherapy in CNS cancer models modulates anti-tumor immunotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 35022322 DOI: 10.1158/1078-0432.CCR-21-2347 |
0.511 |
|
| 2020 |
Kennedy EM, Farkaly T, Grzesik P, Lee J, Denslow A, Hewett J, Bryant J, Behara P, Goshert C, Wambua D, De Almeida A, Jacques J, Deavall D, Rottman JB, Glorioso JC, et al. Design of an Interferon-Resistant Oncolytic HSV-1 Incorporating Redundant Safety Modalities for Improved Tolerability. Molecular Therapy Oncolytics. 18: 476-490. PMID 32953982 DOI: 10.1016/J.Omto.2020.08.004 |
0.406 |
|
| 2020 |
Glorioso JC, Cohen JB, Goins WF, Hall B, Jackson JW, Kohanbash G, Amankulor N, Kaur B, Caligiuri MA, Chiocca EA, Holland EC, Quéva C. Oncolytic HSV Vectors and Anti-Tumor Immunity. Current Issues in Molecular Biology. 41: 381-468. PMID 32938804 DOI: 10.21775/Cimb.041.381 |
0.511 |
|
| 2020 |
Kuroda S, Miyagawa Y, Sato Y, Yamamoto M, Adachi K, Kinoh H, Goins WF, Cohen JB, Glorioso JC, Taniai N, Yoshida H, Okada T. Protocol Optimization for the Production of the Non-Cytotoxic JΔNI5 HSV Vector Deficient in Expression of Immediately Early Genes. Molecular Therapy. Methods & Clinical Development. 17: 612-621. PMID 32300608 DOI: 10.1016/J.Omtm.2020.03.014 |
0.45 |
|
| 2020 |
Otani Y, Yoo JY, Chao S, Liu J, Jaime-Ramirez AC, Lee TJ, Hurwitz B, Yan Y, Dai H, Glorioso JC, Caligiuri MA, Yu J, Kaur B. Oncolytic HSV infected glioma cells activate NOTCH in adjacent tumor cells sensitizing tumors to gamma secretase inhibition. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32139403 DOI: 10.1158/1078-0432.Ccr-19-3420 |
0.556 |
|
| 2020 |
Tuzmen C, Cairns TM, Atanasiu D, Lou H, Saw WT, Hall BL, Cohen JB, Cohen GH, Glorioso JC. Point Mutations in Retargeted gD Eliminate the Sensitivity of EGFR/EGFRvIII-Targeted HSV to Key Neutralizing Antibodies. Molecular Therapy. Methods & Clinical Development. 16: 145-154. PMID 32042851 DOI: 10.1016/J.Omtm.2019.12.013 |
0.399 |
|
| 2020 |
Goins WF, Huang S, Hall B, Marzulli M, Cohen JB, Glorioso JC. Engineering HSV-1 Vectors for Gene Therapy. Methods in Molecular Biology (Clifton, N.J.). 2060: 73-90. PMID 31617173 DOI: 10.1007/978-1-4939-9814-2_4 |
0.356 |
|
| 2020 |
Suzuki T, Saito T, Shimizu N, Shimizu T, Kishida T, Yao M, Goins WF, Glorioso JC, Yoshimura N. Mp54-18 Improvement Of Detrusor Overactivity By Ivermectin-Mediated Activation Of Double Mutant Glycine Receptors Delivered By Herpes Simplex Virus (Hsv) Vectors In Mice With Spinal Cord Injury (Sci) The Journal of Urology. 203. DOI: 10.1097/Ju.0000000000000916.018 |
0.359 |
|
| 2019 |
Sette P, Amankulor N, Li A, Marzulli M, Leronni D, Zhang M, Goins WF, Kaur B, Bolyard C, Cripe TP, Yu J, Chiocca EA, Glorioso JC, Grandi P. GBM-Targeted oHSV Armed with Matrix Metalloproteinase 9 Enhances Anti-tumor Activity and Animal Survival. Molecular Therapy Oncolytics. 15: 214-222. PMID 31890868 DOI: 10.1016/J.Omto.2019.10.005 |
0.598 |
|
| 2019 |
Wirsching HG, Zhang H, Szulzewsky F, Arora S, Grandi P, Cimino PJ, Amankulor N, Campbell JS, McFerrin L, Pattwell SS, Ene C, Hicks A, Ball M, Yan J, Zhang J, ... ... Glorioso JC, et al. Arming oHSV with ULBP3 drives abscopal immunity in lymphocyte-depleted glioblastoma. Jci Insight. 4. PMID 31292299 DOI: 10.1172/Jci.Insight.128217 |
0.374 |
|
| 2019 |
Otani Y, Young Yoo J, Chao S, Liu J, Cristina Jaime-Ramirez A, Jin Lee T, Hurwitz B, Yan Y, Dai H, Glorioso JC, Caligiuri MA, Yu J, Kaur B. CSIG-23. NOTCH ACTIVATION INDUCED BY HSV-1 ENCODED miRNA-H16 SENSITIZES oHSV-TREATED TUMORS TO NOTCH INHIBITOR Neuro-Oncology. 21: vi49-vi49. DOI: 10.1093/Neuonc/Noz175.193 |
0.518 |
|
| 2018 |
Majima T, Mori K, Kadekawa K, Takai S, Funahashi Y, Reinhart B, Goins WF, Gotoh M, Glorioso JC, Yoshimura N. The effect of herpes simplex virus vector-mediated gene therapy of protein phosphatase 1α on bladder overactivity and nociception. Neurourology and Urodynamics. PMID 30499116 DOI: 10.1002/Nau.23882 |
0.46 |
|
| 2018 |
Artusi S, Miyagawa Y, Goins WF, Cohen JB, Glorioso JC. Herpes Simplex Virus Vectors for Gene Transfer to the Central Nervous System. Diseases (Basel, Switzerland). 6. PMID 30110885 DOI: 10.3390/Diseases6030074 |
0.463 |
|
| 2018 |
Han F, Miyagawa Y, Verlengia G, Ingusci S, Soukupova M, Simonato M, Glorioso JC, Cohen JB. Cellular Anti-Silencing Elements Support Transgene Expression from Herpes Simplex Virus Vectors in the Absence of Immediate-Early Gene Expression. Journal of Virology. PMID 29950408 DOI: 10.1128/JVI.00536-18 |
0.4 |
|
| 2018 |
Shimizu N, Doyal MF, Goins WF, Kadekawa K, Wada N, Kanai AJ, de Groat WC, Hirayama A, Uemura H, Glorioso JC, Yoshimura N. Corrigendum to 'Morphological Changes in Different Populations of Bladder Afferent Neurons Detected by Herpes Simplex Virus (HSV) Vectors with Cell-type-specific Promoters in Mice with Spinal Cord Injury' [Neuroscience 364 (2017) 190-201]. Neuroscience. PMID 29704500 DOI: 10.1016/J.Neuroscience.2018.04.021 |
0.369 |
|
| 2018 |
Glorioso JC, Lemoine N. Gene therapy-from small beginnings to where we are now. Gene Therapy. 24: 495-496. PMID 28963564 DOI: 10.1038/Gt.2017.23 |
0.322 |
|
| 2018 |
Hicks A, Grandi P, Paglia M, Miu J, Kwong C, Gursha J, Ball M, Yao W, Wambua D, Farkaly T, Grant K, Salta LV, Ponce L, Glorioso J, Queva C, et al. Abstract 4698: ONCR-1, a novel herpes simplex virus expressing MMP9 and ULBP3 transgenes, evokes potent oncolysis and development of antitumor immune responses Immunology. DOI: 10.1158/1538-7445.Am2018-4698 |
0.384 |
|
| 2017 |
Takai S, Majima T, Reinhart B, Goins WF, Funahashi Y, Gotoh M, Tyagi P, Glorioso JC, Yoshimura N. Effects of herpes simplex virus vectors encoding poreless TRPV1 or protein phosphatase 1α in a rat cystitis model induced by hydrogen peroxide. Gene Therapy. PMID 29057994 DOI: 10.1038/Gt.2017.94 |
0.447 |
|
| 2017 |
Shimizu N, Doyal MF, Goins WF, Kadekawa K, Wada N, Kanai AJ, de Groat WC, Hirayama A, Uemura H, Glorioso JC, Yoshimura N. Morphological Changes in Different Populations of Bladder Afferent Neurons Detected by Herpes Simplex Virus (HSV) Vectors with Cell Type-Specific Promoters in Mice with Spinal Cord Injury. Neuroscience. PMID 28942324 DOI: 10.1016/J.Neuroscience.2017.09.024 |
0.348 |
|
| 2017 |
Miyagawa Y, Verlengia G, Reinhart B, Han F, Uchida H, Zucchini S, Goins WF, Simonato M, Cohen JB, Glorioso JC. Deletion of the Virion Host Shut-off Gene Enhances Neuronal-Selective Transgene Expression from an HSV Vector Lacking Functional IE Genes. Molecular Therapy. Methods & Clinical Development. 6: 79-90. PMID 28702475 DOI: 10.1016/J.Omtm.2017.06.001 |
0.35 |
|
| 2017 |
Verlengia G, Miyagawa Y, Ingusci S, Cohen JB, Simonato M, Glorioso JC. Engineered HSV vector achieves safe long-term transgene expression in the central nervous system. Scientific Reports. 7: 1507. PMID 28473703 DOI: 10.1038/S41598-017-01635-1 |
0.47 |
|
| 2017 |
Iida T, Yi H, Liu S, Ikegami D, Zheng W, Liu Q, Takahashi K, Kashiwagi Y, Goins WF, Glorioso JC, Hao S. MnSOD mediated by HSV vectors in the periaqueductal gray suppresses morphine withdrawal in rats. Gene Therapy. PMID 28368370 DOI: 10.1038/Gt.2017.22 |
0.365 |
|
| 2017 |
Uchida H, Hamada H, Nakano K, Kwon H, Tahara H, Cohen JB, Glorioso JC. Oncolytic Herpes Simplex Virus Vectors Fully Retargeted to Tumor-Associated Antigens. Current Cancer Drug Targets. PMID 28176649 DOI: 10.2174/1568009617666170206105855 |
0.383 |
|
| 2017 |
Finer M, Glorioso J. A brief account of viral vectors and their promise for gene therapy. Gene Therapy. 24: 1-2. PMID 28123184 DOI: 10.1038/Gt.2016.71 |
0.434 |
|
| 2017 |
Dang Y, Loewen R, Glorioso J, Goins W, Loewen N. HSV1 first generation viral vector transduction of porcine eyes F1000research. 6. DOI: 10.7490/F1000Research.1113685.1 |
0.345 |
|
| 2017 |
Takai S, Majima T, Shimizu T, Wada N, Shimizu N, Suzuki T, Takaoka E, Gotoh M, Goins W, Glorioso J, Yoshimura N. PD01-02 GENE THERAPY WITH REPLICATION-DEFICIENT HERPES SIMPLEX VIRUS (HSV) VECTORS ENCODING PORELESS TRPV1 (PL) OR PROTEIN PHOSPHATASE 1α (PP1α) IN A RAT MODEL OF HYDROGEN PEROXIDE-INDUCED CYSTITIS Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.182 |
0.412 |
|
| 2017 |
Shimizu N, Goins WF, Takai S, Wada N, Shimizu T, Suzuki T, Takaoka E, Hirayama A, Uemura H, Glorioso JC, Yoshimura N. Mp42-02 Morphological Changes Of Different Populations Of Bladder Afferent Neurons Detected By Herpes Simplex Virus (Hsv) Vectors With Cell Type-Specific Promoters In Mice With Spinal Cord Injury The Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.1291 |
0.369 |
|
| 2016 |
Okubo Y, Uchida H, Wakata A, Suzuki T, Shibata T, Ikeda H, Yamaguchi M, Cohen JB, Glorioso JC, Tagaya M, Hamada H, Tahara H. Syncytial Mutations Do not Impair the Specificity of Entry and Spread of a Glycoprotein D Receptor-Retargeted Herpes Simplex Virus. Journal of Virology. PMID 27707922 DOI: 10.1128/JVI.01456-16 |
0.306 |
|
| 2016 |
Goins WF, Hall B, Cohen JB, Glorioso JC. Retargeting of herpes simplex virus (HSV) vectors. Current Opinion in Virology. 21: 93-101. PMID 27614209 DOI: 10.1016/j.coviro.2016.08.007 |
0.398 |
|
| 2016 |
Laemmle LL, Cohen JB, Glorioso JC. Constitutive Expression of GATA4 Dramatically Increases the Cardiogenic Potential of D3 Mouse Embryonic Stem Cells. The Open Biotechnology Journal. 10: 248-257. PMID 27441042 DOI: 10.2174/1874070701610010248 |
0.359 |
|
| 2016 |
Reinhart B, Goins WF, Harel A, Chaudhry S, Goss JR, Yoshimura N, de Groat WC, Cohen JB, Glorioso JC. An HSV-based library screen identifies PP1α as a negative TRPV1 regulator with analgesic activity in models of pain. Molecular Therapy. Methods & Clinical Development. 3: 16040. PMID 27382601 DOI: 10.1038/Mtm.2016.40 |
0.447 |
|
| 2016 |
Shibata T, Uchida H, Shiroyama T, Okubo Y, Suzuki T, Ikeda H, Yamaguchi M, Miyagawa Y, Fukuhara T, Cohen JB, Glorioso JC, Watabe T, Hamada H, Tahara H. Development of an oncolytic HSV vector fully retargeted specifically to cellular EpCAM for virus entry and cell-to-cell spread. Gene Therapy. PMID 26905369 DOI: 10.1038/Gt.2016.17 |
0.41 |
|
| 2016 |
Sette P, Li A, Marzulli M, Leronni D, Zhang M, Goins W, Kaur B, Bolyard C, Amankulor N, Glorioso J, Grandi P. 520. Arming a Tumor Targeted Oncolytic HSV Vector with MMP9 for Enhanced Distribution and Killing Activity Molecular Therapy. 24: S207. DOI: 10.1016/S1525-0016(16)33329-9 |
0.565 |
|
| 2016 |
Reinhart B, Leronni D, Cohen JB, Glorioso JC. 114. Replication-Defective HSV Vector Development for Targeted Gene Delivery Molecular Therapy. 24. DOI: 10.1016/S1525-0016(16)32923-9 |
0.529 |
|
| 2016 |
Marzulli M, Cohen JB, Reinhart B, Goins WF, Glorioso JC. 111. HSV Vectors Retargeted for Infection of TrkA Receptor-Bearing, Pain-Sensing C-Fibers Molecular Therapy. 24. DOI: 10.1016/S1525-0016(16)32920-3 |
0.482 |
|
| 2016 |
Takai S, Majima T, Shimizu N, Shimizu T, Wada N, Gotoh M, Goins W, Cohen J, Glorioso J, Yoshimura N. MP30-04 HERPES SIMPLEX VIRUS (HSV) VECTOR-MEDIATED GENE DELIVERY OF PORELESS TRPV1 CHANNELS OR PROTEIN PHOSPHATE 1α (PP1α) REDUCES BLADDER OVERACTIVITY AND NOCICEPTION IN RAT MODEL OF CYSTITIS INDUCED BY HYDROGEN PEROXIDE Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.1236 |
0.412 |
|
| 2015 |
Mazzacurati L, Marzulli M, Reinhart B, Miyagawa Y, Uchida H, Goins WF, Li A, Kaur B, Caligiuri M, Cripe T, Chiocca N, Amankulor N, Cohen JB, Glorioso JC, Grandi P. Use of miRNA Response Sequences to Block Off-target Replication and Increase the Safety of an Unattenuated, Glioblastoma-targeted Oncolytic HSV. Molecular Therapy : the Journal of the American Society of Gene Therapy. 23: 99-107. PMID 28142028 DOI: 10.1038/mt.2014.177 |
0.493 |
|
| 2015 |
Leddon JL, Chen CY, Currier MA, Wang PY, Jung FA, Denton NL, Cripe KM, Haworth KB, Arnold MA, Gross AC, Eubank TD, Goins WF, Glorioso JC, Cohen JB, Grandi P, et al. Oncolytic HSV virotherapy in murine sarcomas differentially triggers an antitumor T-cell response in the absence of virus permissivity. Molecular Therapy Oncolytics. 1: 14010. PMID 27119100 DOI: 10.1038/Mto.2014.10 |
0.401 |
|
| 2015 |
Glorioso JC, Cohen JB, Carlisle DL, Munoz-Sanjuan I, Friedlander RM. Moving toward a gene therapy for Huntington's disease. Gene Therapy. 22: 931-933. PMID 26633828 DOI: 10.1038/Gt.2015.102 |
0.306 |
|
| 2015 |
Wang PY, Swain HM, Kunkler AL, Chen CY, Hutzen BJ, Arnold MA, Streby KA, Collins MH, Dipasquale B, Stanek JR, Conner J, van Kuppevelt TH, Glorioso JC, Grandi P, Cripe TP. Neuroblastomas vary Widely in their sensitivities to herpes simplex virotherapy unrelated to virus receptors and susceptibility. Gene Therapy. PMID 26583803 DOI: 10.1038/Gt.2015.105 |
0.453 |
|
| 2015 |
Nakashima H, Kaufmann JK, Wang PY, Nguyen T, Speranza MC, Kasai K, Okemoto K, Otsuki A, Nakano I, Fernandez S, Goins WF, Grandi P, Glorioso JC, Lawler S, Cripe TP, et al. Histone deacetylase 6 inhibition enhances oncolytic viral replication in glioma. The Journal of Clinical Investigation. 125: 4269-80. PMID 26524593 DOI: 10.1172/Jci80713 |
0.419 |
|
| 2015 |
Majima T, Funahashi Y, Takai S, Goins WF, Gotoh M, Tyagi P, Glorioso JC, Yoshimura N. Herpes Simplex Virus Vector-Mediated Gene Delivery of Poreless TRPV1 Channels Reduces Bladder Overactivity and Nociception in Rats. Human Gene Therapy. PMID 26204493 DOI: 10.1089/Hum.2015.026 |
0.44 |
|
| 2015 |
Guedon JM, Wu S, Zheng X, Churchill CC, Glorioso JC, Liu CH, Liu S, Vulchanova L, Bekker A, Tao YX, Kinchington PR, Goins WF, Fairbanks CA, Hao S. Current gene therapy using viral vectors for chronic pain. Molecular Pain. 11: 27. PMID 25962909 DOI: 10.1186/S12990-015-0018-1 |
0.386 |
|
| 2015 |
Miyagawa Y, Marino P, Verlengia G, Uchida H, Goins WF, Yokota S, Geller DA, Yoshida O, Mester J, Cohen JB, Glorioso JC. Herpes simplex viral-vector design for efficient transduction of nonneuronal cells without cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 112: E1632-41. PMID 25775541 DOI: 10.1073/Pnas.1423556112 |
0.495 |
|
| 2015 |
Mazzacurati L, Marzulli M, Reinhart B, Miyagawa Y, Uchida H, Goins WF, Li A, Kaur B, Caligiuri M, Cripe T, Chiocca EA, Chiocca N, Amankulor N, Cohen JB, Glorioso JC, et al. Use of miRNA response sequences to block off-target replication and increase the safety of an unattenuated, glioblastoma-targeted oncolytic HSV. Molecular Therapy : the Journal of the American Society of Gene Therapy. 23: 99-107. PMID 25200130 DOI: 10.1038/Mt.2014.177 |
0.55 |
|
| 2015 |
Li A, Marzulli M, Zhang M, Goins W, Kaur B, Bolyard C, Amankulor N, Leronni D, Sette P, Cohen J, Glorioso J, Grandi P. Abstract 3546: Arming a tumor targeted oncolytic herpes simplex sirus type 1 with matrix metalloproteinase 9 for enhanced vector distribution and killing activity Cancer Research. 75: 3546-3546. DOI: 10.1158/1538-7445.Am2015-3546 |
0.571 |
|
| 2015 |
Sette P, Li A, Marzulli M, Zhang M, Goins W, Kaur B, Bolyard C, Caligiuri M, Cripe T, Chiocca A, Amankulor N, Glorioso J, Grandi P. ATPS-26ONCOLYTIC VECTORS BASED ON HSV FOR TREATMENT OF GBM Neuro-Oncology. 17: v23.4-v23. DOI: 10.1093/Neuonc/Nov204.26 |
0.575 |
|
| 2015 |
Sette P, Marzulli M, Leronni D, Zhang M, Goins W, Kaur B, Chelsea B, Cripe T, Chiocca A, Glorioso J, Amankulor N, Grandi P. 625. Arming a Tumor Targeted Oncolytic Herpes Simplex Virus Type 1 With Matrix Metalloproteinase 9 for Enhanced Vector Distribution and Killing Activity Molecular Therapy. 23: S248. DOI: 10.1016/S1525-0016(16)34234-4 |
0.582 |
|
| 2015 |
Goins WF, Doyal M, Guedon JG, Marzulli M, Huang S, Kinchington PR, Cohen JB, Glorioso JC. 497. HSV Vector-Mediated Expression of a Novel Drug Activated Pain Signalling Therapeutic Abrogates Pain Molecular Therapy. 23: S198. DOI: 10.1016/S1525-0016(16)34106-5 |
0.369 |
|
| 2015 |
Currier M, Rizvi T, Nartker B, Chen D, Wang P, Patel A, Chaney K, Streby K, Kaur B, Grandi P, Glorioso J, Antonio Chiocca E, Ecsedy J, Conner J, Ratner N, et al. 432. Aurora A Kinase Inhibition Enhances Oncolytic Herpes Simplex Virotherapy in Models of Neuroblastoma Molecular Therapy. 23: S171. DOI: 10.1016/S1525-0016(16)34041-2 |
0.568 |
|
| 2015 |
Miyagawa Y, Han F, Verlengia G, Uchida H, Simonato M, Cohen JB, Glorioso JC. 322. Benign Herpes Simplex Virus Vector Design for Efficient Delivery of Large or Multiple Transgenes To a Diversity of Cells Molecular Therapy. 23: S130. DOI: 10.1016/S1525-0016(16)33931-4 |
0.492 |
|
| 2015 |
Reinhart BL, Marzulli M, Leronni D, Miyagawa YM, Cohen JB, Glorioso JC. 113. HSV Vector Development for Targeted Gene Delivery Molecular Therapy. 23. DOI: 10.1016/S1525-0016(16)33718-2 |
0.509 |
|
| 2015 |
Majima T, Okada H, Kadekawa K, Mori K, Kawamorita N, Gotoh M, Goins W, Glorioso J, Cohen J, Yoshimura N. PD20-05 HERPES SIMPLEX VIRUS (HSV) VECTOR-MEDIATED GENE DELIVERY OF PROTEIN PHOSPHATASE 1α REDUCES BLADDER OVERACTIVITY AND Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.676 |
0.408 |
|
| 2014 |
Guedon JM, Zhang M, Glorioso JC, Goins WF, Kinchington PR. Relief of pain induced by varicella-zoster virus in a rat model of post-herpetic neuralgia using a herpes simplex virus vector expressing enkephalin. Gene Therapy. 21: 694-702. PMID 24830437 DOI: 10.1038/Gt.2014.43 |
0.394 |
|
| 2014 |
Goins WF, Huang S, Cohen JB, Glorioso JC. Engineering HSV-1 vectors for gene therapy. Methods in Molecular Biology (Clifton, N.J.). 1144: 63-79. PMID 24671677 DOI: 10.1007/978-1-4939-0428-0_5 |
0.486 |
|
| 2014 |
Glorioso JC. Herpes simplex viral vectors: late bloomers with big potential. Human Gene Therapy. 25: 83-91. PMID 24502405 DOI: 10.1089/hum.2014.2501 |
0.336 |
|
| 2014 |
Li A, Marzulli M, Mazzacurati L, Uchida H, Cohen J, Glorioso J, Grandi P. Abstract 703: Highly selective HSV virotherapy for glioblastoma Cancer Research. 74: 703-703. DOI: 10.1158/1538-7445.Am2014-703 |
0.432 |
|
| 2014 |
Zhang X, Chang Y, Li A, Glorioso JC, Grandi P, Lotze M, Amankulor N. Abstract 3669: IDH mutant glial cell resistance to natural killer cell cytotoxicity Cancer Research. 74: 3669-3669. DOI: 10.1158/1538-7445.Am2014-3669 |
0.371 |
|
| 2014 |
Li A, Marzulli M, Mazzacurati L, Kaur B, Bolyard C, Cohen J, Goins W, Zhang M, Glorioso J, Grandi P. ET-34 * HIGHLY SELECTIVE HSV VIROTHERAPY FOR TREATMENT OF GLIOBLASTOMA Neuro-Oncology. 16: v87-v87. DOI: 10.1093/Neuonc/Nou255.34 |
0.593 |
|
| 2014 |
Majima T, Kawamorita N, Okada H, Funahashi Y, Gotoh M, Goins W, Glorioso J, Cohen J, Hall B, Harel A, Yoshimura N. MP1-03 HERPES SIMPLEX VIRUS (HSV) VECTOR-MEDIATED GENE DELIVERY OF PROTEIN PHOSPHATASE 1α REDUCES BLADDER OVERACTIVITY AND NOCICEPTION IN RATS Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.101 |
0.45 |
|
| 2013 |
Simonato M, Bennett J, Boulis NM, Castro MG, Fink DJ, Goins WF, Gray SJ, Lowenstein PR, Vandenberghe LH, Wilson TJ, Wolfe JH, Glorioso JC. Progress in gene therapy for neurological disorders. Nature Reviews. Neurology. 9: 277-91. PMID 23609618 DOI: 10.1038/Nrneurol.2013.56 |
0.334 |
|
| 2013 |
Tremblay JP, Xiao X, Aartsma-Rus A, Barbas C, Blau HM, Bogdanove AJ, Boycott K, Braun S, Breakefield XO, Bueren JA, Buschmann M, Byrne BJ, Calos M, Cathomen T, Chamberlain J, ... ... Glorioso J, et al. Translating the genomics revolution: the need for an international gene therapy consortium for monogenic diseases. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 266-8. PMID 23369965 DOI: 10.1038/Mt.2013.4 |
0.337 |
|
| 2013 |
Yokoyama H, Oguchi T, Goins WF, Goss JR, Nishizawa O, de Groat WC, Wolfe D, Krisky DM, Glorioso JC, Yoshimura N. Effects of herpes simplex virus vector-mediated enkephalin gene therapy on bladder overactivity and nociception. Human Gene Therapy. 24: 170-80. PMID 23316929 DOI: 10.1089/Hum.2011.180 |
0.403 |
|
| 2013 |
Wang PY, Currier MA, Hansford L, Kaplan D, Chiocca EA, Uchida H, Goins WF, Cohen JB, Glorioso JC, van Kuppevelt TH, Mo X, Cripe TP. Expression of HSV-1 receptors in EBV-associated lymphoproliferative disease determines susceptibility to oncolytic HSV. Gene Therapy. 20: 761-9. PMID 23254370 DOI: 10.1038/Gt.2012.93 |
0.482 |
|
| 2013 |
Funahashi Y, Oguchi T, Goins WF, Gotoh M, Tyagi P, Goss JR, Glorioso JC, Yoshimura N. Herpes simplex virus vector mediated gene therapy of tumor necrosis factor-α blockade for bladder overactivity and nociception in rats. The Journal of Urology. 189: 366-73. PMID 23174234 DOI: 10.1016/J.Juro.2012.08.192 |
0.347 |
|
| 2013 |
Uchida H, Chan J, Shrivastava I, Reinhart B, Grandi P, Glorioso JC, Cohen JB. Novel mutations in gB and gH circumvent the requirement for known gD Receptors in herpes simplex virus 1 entry and cell-to-cell spread. Journal of Virology. 87: 1430-42. PMID 23152509 DOI: 10.1128/Jvi.02804-12 |
0.445 |
|
| 2013 |
Uchida H, Marzulli M, Nakano K, Goins WF, Chan J, Hong CS, Mazzacurati L, Yoo JY, Haseley A, Nakashima H, Baek H, Kwon H, Kumagai I, Kuroki M, Kaur B, ... ... Glorioso JC, et al. Effective treatment of an orthotopic xenograft model of human glioblastoma using an EGFR-retargeted oncolytic herpes simplex virus. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 561-9. PMID 23070115 DOI: 10.1038/Mt.2012.211 |
0.615 |
|
| 2013 |
Oguchi T, Funahashi Y, Yokoyama H, Nishizawa O, Goins WF, Goss JR, Glorioso JC, Yoshimura N. Effect of herpes simplex virus vector-mediated interleukin-4 gene therapy on bladder overactivity and nociception. Gene Therapy. 20: 194-200. PMID 22402319 DOI: 10.1038/Gt.2012.24 |
0.395 |
|
| 2013 |
Oguchi T, Yokoyama H, Funahashi Y, Nishizawa O, Yoshikawa S, Goins WF, Goss JR, Glorioso JC, Yoshimura N. 871 EFFECT OF HERPES SIMPLEX VIRUS (HSV) VECTOR-MEDIATED INTERLEUKIN 4 GENE THERAPY ON ENHANCED BLADDER PAIN BEHAVIOR IN RATS WITH CYCLOPHOSPHAMIDE (CYP)-INDUCED CYSTITIS Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.440 |
0.445 |
|
| 2012 |
Reinhart B, Mazzacurati L, Forero A, Hong CS, Eguchi J, Okada H, Fellows W, Niranjan A, Cohen JB, Glorioso JC, Grandi P. Inhibition of Indoleamine-2,3-dioxygenase (IDO) in Glioblastoma Cells by Oncolytic Herpes Simplex Virus. Advances in Virology. 2012: 815465. PMID 22924042 DOI: 10.1155/2012/815465 |
0.491 |
|
| 2012 |
Yoo JY, Pradarelli J, Haseley A, Wojton J, Kaka A, Bratasz A, Alvarez-Breckenridge CA, Yu JG, Powell K, Mazar AP, Teknos TN, Chiocca EA, Glorioso JC, Old M, Kaur B. Copper chelation enhances antitumor efficacy and systemic delivery of oncolytic HSV. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 4931-41. PMID 22753591 DOI: 10.1158/1078-0432.Ccr-12-0697 |
0.559 |
|
| 2012 |
Goins WF, Cohen JB, Glorioso JC. Gene therapy for the treatment of chronic peripheral nervous system pain. Neurobiology of Disease. 48: 255-70. PMID 22668775 DOI: 10.1016/J.Nbd.2012.05.005 |
0.353 |
|
| 2012 |
Zhu X, McTiernan CF, Rajagopalan N, Shah H, Fischer D, Toyoda Y, Letts D, Bortinger J, Gibson G, Xiang W, McCurry K, Mathier M, Glorioso JC, London B. Immunosuppression decreases inflammation and increases AAV6-hSERCA2a-mediated SERCA2a expression. Human Gene Therapy. 23: 722-32. PMID 22482463 DOI: 10.1089/Hum.2011.108 |
0.331 |
|
| 2012 |
Salerno KM, Jing X, Diges CM, Cornuet PK, Glorioso JC, Albers KM. Sox11 modulates brain-derived neurotrophic factor expression in an exon promoter-specific manner. Journal of Neuroscience Research. 90: 1011-9. PMID 22331573 DOI: 10.1002/Jnr.23010 |
0.303 |
|
| 2012 |
Haseley A, Boone S, Wojton J, Yu L, Yoo JY, Yu J, Kurozumi K, Glorioso JC, Caligiuri MA, Kaur B. Extracellular matrix protein CCN1 limits oncolytic efficacy in glioma. Cancer Research. 72: 1353-62. PMID 22282654 DOI: 10.1158/0008-5472.Can-11-2526 |
0.595 |
|
| 2012 |
Jing X, Wang T, Huang S, Glorioso JC, Albers KM. The transcription factor Sox11 promotes nerve regeneration through activation of the regeneration-associated gene Sprr1a. Experimental Neurology. 233: 221-32. PMID 22024412 DOI: 10.1016/J.Expneurol.2011.10.005 |
0.343 |
|
| 2012 |
Oguchi T, Yokoyama H, Funahashi Y, Nishizawa O, Goins WF, Goss JR, Glorioso JC, Yoshimura N. 40 ENHANCEMENT OF GLYCINE EFFECTS ON BLADDER OVERACTIVITY AND NOCICEPTION BY HERPES SIMPLEX VIRUS (HSV) VECTOR-MEDIATED GLYCINE RECEPTOR GENE THERAPY Journal of Urology. 187. DOI: 10.1016/J.Juro.2012.02.083 |
0.431 |
|
| 2011 |
Glorioso JC. Non-coding RNAs and the advent of new directions in therapeutics. Gene Therapy. 18: 1103. PMID 22158030 DOI: 10.1038/Gt.2011.150 |
0.32 |
|
| 2011 |
Goins WF, Krisky DM, Wechuck JB, Wolfe D, Huang S, Glorioso JC. Generation of replication-competent and -defective HSV vectors. Cold Spring Harbor Protocols. 2011: pdb.prot5615. PMID 21536761 DOI: 10.1101/Pdb.Prot5615 |
0.498 |
|
| 2011 |
Nakano K, Kobayashi M, Nakamura K, Nakanishi T, Asano R, Kumagai I, Tahara H, Kuwano M, Cohen JB, Glorioso JC. Mechanism of HSV infection through soluble adapter-mediated virus bridging to the EGF receptor. Virology. 413: 12-8. PMID 21382632 DOI: 10.1016/J.Virol.2011.02.014 |
0.413 |
|
| 2011 |
Dmitrieva N, Yu L, Viapiano M, Cripe TP, Chiocca EA, Glorioso JC, Kaur B. Chondroitinase ABC I-mediated enhancement of oncolytic virus spread and antitumor efficacy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 1362-72. PMID 21177410 DOI: 10.1158/1078-0432.Ccr-10-2213 |
0.506 |
|
| 2011 |
Baek H, Uchida H, Jun K, Kim JH, Kuroki M, Cohen JB, Glorioso JC, Kwon H. Bispecific adapter-mediated retargeting of a receptor-restricted HSV-1 vector to CEA-bearing tumor cells. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 507-14. PMID 20924362 DOI: 10.1038/mt.2010.207 |
0.359 |
|
| 2011 |
Funahashi Y, Oguchi T, Gotoh M, Goins WF, Goss JR, Glorioso JC, Yoshimura N. 949 HERPES SIMPLEX VIRUS (HSV) VECTOR-MEDIATED GENE THERAPY OF TUMOR NECROSIS FACTOR-α (TNFα) BLOCKADE FOR BLADDER OVERACTIVITY AND NOCICEPTION Journal of Urology. 185. DOI: 10.1016/J.Juro.2011.02.894 |
0.455 |
|
| 2011 |
Oguchi T, Yokoyama H, Nishizawa O, Goins WF, Goss JR, Glorioso JC, Yoshimura N. 796 EFFECTS OF HERPES SIMPLEX VIRUS VECTOR-MEDIATED INTERLEUKIN-4 GENE THERAPY ON BLADDER PAIN AND OVERACTIVITY Journal of Urology. 185. DOI: 10.1016/J.Juro.2011.02.614 |
0.457 |
|
| 2010 |
Uchida H, Chan J, Goins WF, Grandi P, Kumagai I, Cohen JB, Glorioso JC. A double mutation in glycoprotein gB compensates for ineffective gD-dependent initiation of herpes simplex virus type 1 infection. Journal of Virology. 84: 12200-9. PMID 20861246 DOI: 10.1128/Jvi.01633-10 |
0.376 |
|
| 2010 |
Miyazato M, Sugaya K, Saito S, Chancellor MB, Goins WF, Goss JR, de Groat WC, Glorioso JC, Yoshimura N. Suppression of detrusor-sphincter dyssynergia by herpes simplex virus vector mediated gene delivery of glutamic acid decarboxylase in spinal cord injured rats. The Journal of Urology. 184: 1204-10. PMID 20663524 DOI: 10.1016/J.Juro.2010.04.066 |
0.374 |
|
| 2010 |
Yoshimura N, Kato R, Chancellor MB, Nelson JB, Glorioso JC. Gene therapy as future treatment of erectile dysfunction. Expert Opinion On Biological Therapy. 10: 1305-14. PMID 20662742 DOI: 10.1517/14712598.2010.510510 |
0.363 |
|
| 2010 |
Hong CS, Fellows W, Niranjan A, Alber S, Watkins S, Cohen JB, Glorioso JC, Grandi P. Ectopic matrix metalloproteinase-9 expression in human brain tumor cells enhances oncolytic HSV vector infection. Gene Therapy. 17: 1200-5. PMID 20463757 DOI: 10.1038/Gt.2010.66 |
0.395 |
|
| 2010 |
Wolfe D, Craft AM, Cohen JB, Glorioso JC. A herpes simplex virus vector system for expression of complex cellular cDNA libraries. Journal of Virology. 84: 7360-8. PMID 20463073 DOI: 10.1128/JVI.02388-09 |
0.383 |
|
| 2010 |
Frampton AR, Uchida H, von Einem J, Goins WF, Grandi P, Cohen JB, Osterrieder N, Glorioso JC. Equine herpesvirus type 1 (EHV-1) utilizes microtubules, dynein, and ROCK1 to productively infect cells. Veterinary Microbiology. 141: 12-21. PMID 19713056 DOI: 10.1016/J.Vetmic.2009.07.035 |
0.419 |
|
| 2010 |
Uchida H, Chan J, Goins WF, Grandi P, Kumagai I, Cohen JB, Glorioso JC. Abstract 584: Identification of mutations in HSV-1 envelope glycoprotein B that enhance retargeted infection Cancer Research. 70: 584-584. DOI: 10.1158/1538-7445.Am10-584 |
0.464 |
|
| 2010 |
Yokoyama H, Oguchi T, Nishizawa O, Goins W, Goss J, Glorioso J, Yoshimura N. 1038 ENKEPHALIN GENE THERAPY USING A HERPES SIMPLEX VIRUS VECTOR SUPPRESSES CYTOKINE ELEVATION IN THE BLADDER AND URINE OF RATS WITH CYSTITIS Journal of Urology. 183. DOI: 10.1016/J.Juro.2010.02.2116 |
0.454 |
|
| 2009 |
Yokoyama H, Sasaki K, Franks ME, Goins WF, Goss JR, de Groat WC, Glorioso JC, Chancellor MB, Yoshimura N. Gene therapy for bladder overactivity and nociception with herpes simplex virus vectors expressing preproenkephalin. Human Gene Therapy. 20: 63-71. PMID 20377371 DOI: 10.1089/Hum.2008.094 |
0.475 |
|
| 2009 |
Glorioso JC, Fink DJ. Gene therapy for pain: introduction to the special issue. Gene Therapy. 16: 453-4. PMID 19357693 DOI: 10.1038/Gt.2009.18 |
0.327 |
|
| 2009 |
Grandi P, Peruzzi P, Reinhart B, Cohen JB, Chiocca EA, Glorioso JC. Design and application of oncolytic HSV vectors for glioblastoma therapy. Expert Review of Neurotherapeutics. 9: 505-17. PMID 19344302 DOI: 10.1586/Ern.09.9 |
0.457 |
|
| 2009 |
Miyazato M, Sugaya K, Goins WF, Wolfe D, Goss JR, Chancellor MB, de Groat WC, Glorioso JC, Yoshimura N. Herpes simplex virus vector-mediated gene delivery of glutamic acid decarboxylase reduces detrusor overactivity in spinal cord-injured rats. Gene Therapy. 16: 660-8. PMID 19225548 DOI: 10.1038/gt.2009.5 |
0.311 |
|
| 2009 |
Uchida H, Shah WA, Ozuer A, Frampton AR, Goins WF, Grandi P, Cohen JB, Glorioso JC. Generation of herpesvirus entry mediator (HVEM)-restricted herpes simplex virus type 1 mutant viruses: resistance of HVEM-expressing cells and identification of mutations that rescue nectin-1 recognition. Journal of Virology. 83: 2951-61. PMID 19129446 DOI: 10.1128/Jvi.01449-08 |
0.357 |
|
| 2009 |
Glorioso JC, Fink DJ. Herpes vector-mediated gene transfer in the treatment of chronic pain. Molecular Therapy : the Journal of the American Society of Gene Therapy. 17: 13-8. PMID 18841093 DOI: 10.1038/Mt.2008.213 |
0.37 |
|
| 2009 |
Grant KG, Krisky DM, Ataai MM, Glorioso JC. Engineering cell lines for production of replication defective HSV-1 gene therapy vectors. Biotechnology and Bioengineering. 102: 1087-97. PMID 18828174 DOI: 10.1002/Bit.22123 |
0.528 |
|
| 2009 |
Kato R, Wolfe D, Coyle CH, Wechuck JB, Tyagi P, Tsukamoto T, Nelson JB, Glorioso JC, Chancellor MB, Yoshimura N. Herpes simplex virus vector-mediated delivery of neurturin rescues erectile dysfunction of cavernous nerve injury. Gene Therapy. 16: 26-33. PMID 18668142 DOI: 10.1038/Gt.2008.132 |
0.377 |
|
| 2009 |
Hao S, Wolfe D, Glorioso JC, Mata M, Fink DJ. Effects of transgene-mediated endomorphin-2 in inflammatory pain. European Journal of Pain (London, England). 13: 380-6. PMID 18567517 DOI: 10.1016/J.Ejpain.2008.05.008 |
0.387 |
|
| 2009 |
KATO R, BENNETT NE, KIM JH, WOLFE D, COYLE CH, HUANG S, WECHUCK JB, GOINS WF, DE MIGUEL F, TSUKAMOTO T, NELSON JB, GLORIOSO JC, CHANCELLOR MB, YOSHIMURA N. Gene Therapy for Neurogenic Erectile Dysfunction Luts: Lower Urinary Tract Symptoms. 1: S44-S47. DOI: 10.1111/J.1757-5672.2009.00045.X |
0.386 |
|
| 2009 |
Cascio M, Goss JR, Huang S, Krisky DM, Clarke RJ, Johnson JW, Glorioso JC. Targeted Delivery of Glycine Receptors to Peripheral Neurons as Treatment for Pain Biophysical Journal. 96: 487a. DOI: 10.1016/J.Bpj.2008.12.2511 |
0.362 |
|
| 2008 |
Srinivasan R, Wolfe D, Goss J, Watkins S, de Groat WC, Sculptoreanu A, Glorioso JC. Protein kinase C epsilon contributes to basal and sensitizing responses of TRPV1 to capsaicin in rat dorsal root ganglion neurons. The European Journal of Neuroscience. 28: 1241-54. PMID 18973552 DOI: 10.1111/J.1460-9568.2008.06438.X |
0.579 |
|
| 2008 |
Srinivasan R, Fink DJ, Glorioso JC. HSV vectors for gene therapy of chronic pain. Current Opinion in Molecular Therapeutics. 10: 449-55. PMID 18830920 |
0.561 |
|
| 2008 |
Craft AM, Krisky DM, Wechuck JB, Lobenhofer EK, Jiang Y, Wolfe DP, Glorioso JC. Herpes simplex virus-mediated expression of Pax3 and MyoD in embryoid bodies results in lineage-Related alterations in gene expression profiles. Stem Cells (Dayton, Ohio). 26: 3119-29. PMID 18787207 DOI: 10.1634/Stemcells.2008-0417 |
0.449 |
|
| 2008 |
Goins WF, Krisky DM, Wechuck JB, Huang S, Glorioso JC. Construction and production of recombinant herpes simplex virus vectors. Methods in Molecular Biology (Clifton, N.J.). 433: 97-113. PMID 18679619 DOI: 10.1007/978-1-59745-237-3_6 |
0.515 |
|
| 2008 |
Li H, Baskaran R, Krisky DM, Bein K, Grandi P, Cohen JB, Glorioso JC. Chk2 is required for HSV-1 ICP0-mediated G2/M arrest and enhancement of virus growth. Virology. 375: 13-23. PMID 18321553 DOI: 10.1016/J.Virol.2008.01.038 |
0.459 |
|
| 2007 |
McTiernan CF, Mathier MA, Zhu X, Xiao X, Klein E, Swan CH, Mehdi H, Gibson G, Trichel AM, Glorioso JC, Feldman AM, McCurry KR, London B. Myocarditis following adeno-associated viral gene expression of human soluble TNF receptor (TNFRII-Fc) in baboon hearts. Gene Therapy. 14: 1613-22. PMID 17851548 DOI: 10.1038/Sj.Gt.3303020 |
0.394 |
|
| 2007 |
Srinivasan R, Huang S, Chaudhry S, Sculptoreanu A, Krisky D, Cascio M, Friedman PA, de Groat WC, Wolfe D, Glorioso JC. An HSV vector system for selection of ligand-gated ion channel modulators. Nature Methods. 4: 733-9. PMID 17676048 DOI: 10.1038/Nmeth1077 |
0.593 |
|
| 2007 |
Frampton AR, Stolz DB, Uchida H, Goins WF, Cohen JB, Glorioso JC. Equine herpesvirus 1 enters cells by two different pathways, and infection requires the activation of the cellular kinase ROCK1. Journal of Virology. 81: 10879-89. PMID 17670830 DOI: 10.1128/Jvi.00504-07 |
0.364 |
|
| 2007 |
Kato R, Wolfe D, Coyle CH, Huang S, Wechuck JB, Goins WF, Krisky DM, Tsukamoto T, Nelson JB, Glorioso JC, Chancellor MB, Yoshimura N. Herpes simplex virus vector-mediated delivery of glial cell line-derived neurotrophic factor rescues erectile dysfunction following cavernous nerve injury. Gene Therapy. 14: 1344-52. PMID 17611585 DOI: 10.1038/Sj.Gt.3302990 |
0.37 |
|
| 2007 |
Chattopadhyay M, Mata M, Goss J, Wolfe D, Huang S, Glorioso JC, Fink DJ. Prolonged preservation of nerve function in diabetic neuropathy in mice by herpes simplex virus-mediated gene transfer. Diabetologia. 50: 1550-8. PMID 17508196 DOI: 10.1007/S00125-007-0702-4 |
0.404 |
|
| 2007 |
Goss JR, Goins WF, Glorioso JC. Gene therapy applications for the treatment of neuropathic pain. Expert Review of Neurotherapeutics. 7: 487-506. PMID 17492900 DOI: 10.1586/14737175.7.5.487 |
0.313 |
|
| 2007 |
Hao S, Mata M, Glorioso JC, Fink DJ. Gene transfer to interfere with TNFalpha signaling in neuropathic pain. Gene Therapy. 14: 1010-6. PMID 17443214 DOI: 10.1038/Sj.Gt.3302950 |
0.349 |
|
| 2007 |
Wolfe D, Hao S, Hu J, Srinivasan R, Goss J, Mata M, Fink DJ, Glorioso JC. Engineering an endomorphin-2 gene for use in neuropathic pain therapy. Pain. 133: 29-38. PMID 17395375 DOI: 10.1016/J.Pain.2007.02.003 |
0.616 |
|
| 2007 |
Tsvitov M, Frampton AR, Shah WA, Wendell SK, Ozuer A, Kapacee Z, Goins WF, Cohen JB, Glorioso JC. Characterization of soluble glycoprotein D-mediated herpes simplex virus type 1 infection. Virology. 360: 477-91. PMID 17157347 DOI: 10.1016/J.Virol.2006.10.039 |
0.787 |
|
| 2007 |
Kato R, Wolfe DP, Coyle CH, Wechuck JB, de Miguel F, Tsukamoto T, Nelson JB, Chancellor MB, Glorioso JC, Yoshimura N. 673: Herpes Simplex Virus Vector-Mediated Delivery of a Penile Neurotrophic Factor, Neurturin, Rescues Erectile Dysfunction Following Cavernous Nerve Injury Journal of Urology. 177: 226-226. DOI: 10.1016/S0022-5347(18)30913-3 |
0.381 |
|
| 2007 |
Kato R, Wolfe DP, Coyle CH, Huang S, Wechuck JB, Goins WF, de Miguel F, Tsukamoto T, Nelson JB, Chancellor MB, Glorioso JC, Yoshimura N. 271: Herpes Simplex Virus Vector-Mediated Delivery of Glial Cell Line-Derived Neurotrophic Factor Rescues Erectile Dysfunction of a Nerve-Sparing Radical Prostatectomy Model Journal of Urology. 177: 91-91. DOI: 10.1016/S0022-5347(18)30536-6 |
0.41 |
|
| 2007 |
Burton EA, Glorioso JC. Herpes simplex virus vectors for gene therapy of lysosomal storage disorders Lysosomal Storage Disorders. 111-131. DOI: 10.1007/978-0-387-70909-3_9 |
0.332 |
|
| 2006 |
Puskovic V, Wolfe D, Wechuck J, Krisky D, Collins J, Glorioso JC, Fink DJ, Mata M. HSV-mediated delivery of erythropoietin restores dopaminergic function in MPTP-treated mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. 14: 710-5. PMID 16949343 DOI: 10.1016/J.Ymthe.2006.07.004 |
0.359 |
|
| 2006 |
Jiang C, Glorioso JC, Ataai M. Presence of imidazole in loading buffer prevents formation of free radical in immobilized metal affinity chromatography and dramatically improves the recovery of herpes simplex virus type 1 gene therapy vectors. Journal of Chromatography. A. 1121: 40-5. PMID 16735041 DOI: 10.1016/J.Chroma.2006.04.071 |
0.418 |
|
| 2006 |
Jiang C, Ataai M, Ozuer A, Krisky D, Wechuck J, Pornsuwan S, Pourarian F, Glorioso JC. Inactivation of herpes simplex type 1 gene vector on immobilized metal affinity chromatography: oxidative damage by hydroxyl free radicals and its prevention. Biotechnology and Bioengineering. 95: 48-57. PMID 16673413 DOI: 10.1002/Bit.20943 |
0.371 |
|
| 2006 |
Hong CS, Goins WF, Goss JR, Burton EA, Glorioso JC. Herpes simplex virus RNAi and neprilysin gene transfer vectors reduce accumulation of Alzheimer's disease-related amyloid-beta peptide in vivo. Gene Therapy. 13: 1068-79. PMID 16541122 DOI: 10.1038/Sj.Gt.3302719 |
0.358 |
|
| 2006 |
Hao S, Mata M, Glorioso JC, Fink DJ. HSV-mediated expression of interleukin-4 in dorsal root ganglion neurons reduces neuropathic pain. Molecular Pain. 2: 6. PMID 16503976 DOI: 10.1186/1744-8069-2-6 |
0.332 |
|
| 2006 |
Kwon H, Bai Q, Baek HJ, Felmet K, Burton EA, Goins WF, Cohen JB, Glorioso JC. Soluble V domain of Nectin-1/HveC enables entry of herpes simplex virus type 1 (HSV-1) into HSV-resistant cells by binding to viral glycoprotein D. Journal of Virology. 80: 138-48. PMID 16352538 DOI: 10.1128/JVI.80.1.138-148.2006 |
0.341 |
|
| 2006 |
Sunyog AM, Wolfe D, Wechuck J, Krisky D, Jiang Y, Glorioso J. 355. A Platform for Gene Delivery to Embryonic Stem Cells Using HSV Molecular Therapy. 13: S135. DOI: 10.1016/J.Ymthe.2006.08.413 |
0.378 |
|
| 2006 |
Srinivasan R, Wolfe D, Huang S, Krisky D, Sculptoreanu A, Friedman PA, de Groat WC, Glorioso JC. 164. HSV-1 Vector-Based Assay To Identify Inhibitors of the Vanilloid Receptor Molecular Therapy. 13: S63-S64. DOI: 10.1016/J.Ymthe.2006.08.187 |
0.656 |
|
| 2006 |
Baek H, Kyoung J, Park J, Lee K, Goins WF, Cohen JB, Glorioso JC, Kwon H. 155. Soluble HVEM Mediates Herpes Simplex Virus 1 (HSV-1) Infection of gD Receptor-Negative Cells Molecular Therapy. 13: S61. DOI: 10.1016/J.Ymthe.2006.08.178 |
0.481 |
|
| 2006 |
Grant KG, Krisky DM, Ataai MM, Glorioso JC. 1110. Engineering Cell Lines for the Production of Highly Replication Defective HSV-1 Vectors Molecular Therapy. 13. DOI: 10.1016/J.Ymthe.2006.08.1216 |
0.479 |
|
| 2006 |
Srinivasan R, Sculptoreanu A, Wolfe D, Wechuck J, Watkins S, de Groat WC, Glorioso JC. 1071. Development and Characterization of HSV-1 Vector-Expressed Dominant Negative PKC epsilon for Pain Therapy Molecular Therapy. 13: S411. DOI: 10.1016/J.Ymthe.2006.08.1170 |
0.623 |
|
| 2005 |
Burton EA, Fink DJ, Glorioso JC. Replication-defective genomic HSV gene therapy vectors: design, production and CNS applications. Current Opinion in Molecular Therapeutics. 7: 326-36. PMID 16121698 |
0.432 |
|
| 2005 |
Hao S, Mata M, Wolfe D, Huang S, Glorioso JC, Fink DJ. Gene transfer of glutamic acid decarboxylase reduces neuropathic pain. Annals of Neurology. 57: 914-8. PMID 15929041 DOI: 10.1002/Ana.20483 |
0.399 |
|
| 2005 |
Chattopadhyay M, Wolfe D, Mata M, Huang S, Glorioso JC, Fink DJ. Long-term neuroprotection achieved with latency-associated promoter-driven herpes simplex virus gene transfer to the peripheral nervous system. Molecular Therapy : the Journal of the American Society of Gene Therapy. 12: 307-13. PMID 15927533 DOI: 10.1016/J.Ymthe.2005.04.009 |
0.421 |
|
| 2005 |
Frampton AR, Goins WF, Nakano K, Burton EA, Glorioso JC. HSV trafficking and development of gene therapy vectors with applications in the nervous system. Gene Therapy. 12: 891-901. PMID 15908995 DOI: 10.1038/Sj.Gt.3302545 |
0.495 |
|
| 2005 |
Chattopadhyay M, Krisky D, Wolfe D, Glorioso JC, Mata M, Fink DJ. HSV-mediated gene transfer of vascular endothelial growth factor to dorsal root ganglia prevents diabetic neuropathy. Gene Therapy. 12: 1377-84. PMID 15843809 DOI: 10.1038/Sj.Gt.3302533 |
0.346 |
|
| 2005 |
Bennett NE, Kim JH, Wolfe DP, Sasaki K, Yoshimura N, Goins WF, Huang S, Nelson JB, de Groat WC, Glorioso JC, Chancellor MB. Improvement in erectile dysfunction after neurotrophic factor gene therapy in diabetic rats. The Journal of Urology. 173: 1820-4. PMID 15821595 DOI: 10.1097/01.Ju.0000158056.66236.1F |
0.361 |
|
| 2005 |
Nakano K, Asano R, Tsumoto K, Kwon H, Goins WF, Kumagai I, Cohen JB, Glorioso JC. Herpes simplex virus targeting to the EGF receptor by a gD-specific soluble bridging molecule. Molecular Therapy : the Journal of the American Society of Gene Therapy. 11: 617-26. PMID 15771964 DOI: 10.1016/j.ymthe.2004.12.012 |
0.313 |
|
| 2005 |
Nakano K, Todo T, Zhao G, Yamaguchi K, Kuroki S, Cohen JB, Glorioso JC, Tanaka M. Enhanced efficacy of conditionally replicating herpes simplex virus (G207) combined with 5-fluorouracil and surgical resection in peritoneal cancer dissemination models. The Journal of Gene Medicine. 7: 638-48. PMID 15754306 DOI: 10.1002/Jgm.700 |
0.329 |
|
| 2005 |
Frampton AR, Goins WF, Cohen JB, von Einem J, Osterrieder N, O'Callaghan DJ, Glorioso JC. Equine herpesvirus 1 utilizes a novel herpesvirus entry receptor. Journal of Virology. 79: 3169-73. PMID 15709036 DOI: 10.1128/Jvi.79.5.3169-3173.2005 |
0.329 |
|
| 2005 |
Moriuchi S, Glorioso JC, Maruno M, Izumoto S, Wolfe D, Huang S, Cohen JB, Yoshimine T. Combination gene therapy for glioblastoma involving herpes simplex virus vector-mediated codelivery of mutant IkappaBalpha and HSV thymidine kinase. Cancer Gene Therapy. 12: 487-96. PMID 15692608 DOI: 10.1038/Sj.Cgt.7700816 |
0.481 |
|
| 2005 |
Fradette J, Wolfe D, Goins WF, Huang S, Flanigan RM, Glorioso JC. HSV vector-mediated transduction and GDNF secretion from adipose cells. Gene Therapy. 12: 48-58. PMID 15470480 DOI: 10.1038/Sj.Gt.3302359 |
0.455 |
|
| 2005 |
Hong C, Goss JR, Goins WF, Glorioso JC. 951. Evaluation of HSV-Mediated Alzheimer Gene Therapy Vectors Using Novel Alzheimer Mouse Model: Applications of siRNA and Neprilysin Vectors to Adjust the Metabolic Imbalance of A|[beta]| in Alzheimer's Disease Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.494 |
0.41 |
|
| 2005 |
Sunyog AM, Wolfe DP, Krisky D, Wechuck J, Jiang Y, Glorioso JC. 760. Development of an HSV-Based Model System to Identify Factors Acting in Embryonic Myogenesis Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.301 |
0.372 |
|
| 2005 |
Krisky DM, Wechuck J, Wolfe D, Huang S, Ozuer A, Glorioso JC. 757. Replication Defective HSV-1 Immediate Early (IE) Gene Mutants: A Comparison of Vector Toxicity Versus Transgene Expression Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.298 |
0.497 |
|
| 2005 |
Goss JR, Chattopadhyay M, Goins WF, Wolfe D, Mata M, Glorioso JC, Fink DJ. 671. Nerve Growth Factor and Neurotrophin-3 Delivered by HSV Gene Transfer Reverses Diabetic Neuropathy Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.211 |
0.378 |
|
| 2005 |
Wolfe D, Hao S, Hu J, Mata M, Glorioso J, Fink D. 640. A Novel Herpes Simplex Virus Vector Expressing Endomorphin-2: Characterization and Antinociceptive Properties Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.180 |
0.492 |
|
| 2005 |
Nakano K, Goins WF, Cohen JB, Glorioso JC. 162. Targeted HSV-1 Infection by Adapters for Glycoprotein D: Variable Infection Efficiency Dependent on Ligand Choice Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.166 |
0.356 |
|
| 2005 |
Kwon H, Bai Q, Felmet K, Baek H, Kim G, Goins WF, Cohen JF, Glorioso JC. 161. Targeting HSV Infection to gD Receptor-Negative Cells Using Soluble gD Receptors Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.165 |
0.453 |
|
| 2005 |
Fradette J, Wendell SK, Wechuck J, Krisky DM, Wolfe D, Goins WF, Glorioso JC. 156. Update on Genomic HSV Vector-Related Cytotoxicity: A Vector Preserving the Differentiation Potential of Embryonic and Adult Adipose Stem Cells Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.160 |
0.45 |
|
| 2004 |
Glorioso JC, Fink DJ. Herpes vector-mediated gene transfer in treatment of diseases of the nervous system. Annual Review of Microbiology. 58: 253-71. PMID 15487938 DOI: 10.1146/Annurev.Micro.58.030603.123709 |
0.467 |
|
| 2004 |
Sasaki K, Chancellor MB, Goins WF, Phelan MW, Glorioso JC, de Groat WC, Yoshimura N. Gene therapy using replication-defective herpes simplex virus vectors expressing nerve growth factor in a rat model of diabetic cystopathy. Diabetes. 53: 2723-30. PMID 15448108 DOI: 10.2337/Diabetes.53.10.2723 |
0.373 |
|
| 2004 |
Jiang C, Wechuck JB, Goins WF, Krisky DM, Wolfe D, Ataai MM, Glorioso JC. Immobilized cobalt affinity chromatography provides a novel, efficient method for herpes simplex virus type 1 gene vector purification. Journal of Virology. 78: 8994-9006. PMID 15308696 DOI: 10.1128/Jvi.78.17.8994-9006.2004 |
0.467 |
|
| 2004 |
Wolfe D, Niranjan A, Trichel A, Wiley C, Ozuer A, Kanal E, Kondziolka D, Krisky D, Goss J, Deluca N, Murphey-Corb M, Glorioso JC. Safety and biodistribution studies of an HSV multigene vector following intracranial delivery to non-human primates. Gene Therapy. 11: 1675-84. PMID 15306839 DOI: 10.1038/Sj.Gt.3302336 |
0.378 |
|
| 2004 |
Puskovic V, Wolfe D, Goss J, Huang S, Mata M, Glorioso JC, Fink DJ. Prolonged biologically active transgene expression driven by HSV LAP2 in brain in vivo. Molecular Therapy : the Journal of the American Society of Gene Therapy. 10: 67-75. PMID 15233943 DOI: 10.1016/J.Ymthe.2004.04.004 |
0.443 |
|
| 2004 |
Trybala E, Olofsson S, Mårdberg K, Svennerholm B, Umemoto K, Glorioso JC, Bergström T. Structural and functional features of the polycationic peptide required for inhibition of herpes simplex virus invasion of cells. Antiviral Research. 62: 125-34. PMID 15130536 DOI: 10.1016/J.Antiviral.2003.12.007 |
0.375 |
|
| 2004 |
Wolfe D, Wechuck JB, Krisky DM, Goff JP, Goins WF, Ozuer A, Epperly ME, Greenberger JS, Fink DJ, Glorioso JC. Delivery of herpes simplex virus-based vectors to stem cells. Methods in Molecular Biology (Clifton, N.J.). 246: 339-52. PMID 14970603 DOI: 10.1385/1-59259-650-9:339 |
0.509 |
|
| 2004 |
Niranjan A, Wolfe D, Fellows W, Goins WF, Glorioso JC, Kondziolka D, Lunsford LD. Gene transfer to glial tumors using herpes simplex virus. Methods in Molecular Biology (Clifton, N.J.). 246: 323-37. PMID 14970602 DOI: 10.1385/1-59259-650-9:323 |
0.483 |
|
| 2004 |
Goss JR, Natsume A, Wolfe D, Mata M, Glorioso JC, Fink DJ. Delivery of herpes simplex virus-based vectors to the nervous system. Methods in Molecular Biology (Clifton, N.J.). 246: 309-22. PMID 14970601 DOI: 10.1385/1-59259-650-9:309 |
0.437 |
|
| 2004 |
Goins WF, Wolfe D, Krisky DM, Bai Q, Burton EA, Fink DJ, Glorioso JC. Delivery using herpes simplex virus: an overview. Methods in Molecular Biology (Clifton, N.J.). 246: 257-99. PMID 14970599 DOI: 10.1385/1-59259-650-9:257 |
0.485 |
|
| 2004 |
Chattopadhyay M, Goss J, Wolfe D, Goins WC, Huang S, Glorioso JC, Mata M, Fink DJ. Protective effect of herpes simplex virus-mediated neurotrophin gene transfer in cisplatin neuropathy. Brain : a Journal of Neurology. 127: 929-39. PMID 14749293 DOI: 10.1093/Brain/Awh103 |
0.459 |
|
| 2004 |
Mata M, Glorioso JC, Fink DJ. Gene therapy: novel treatments for polyneuropathy and chronic pain. Current Neurology and Neuroscience Reports. 4: 1-2. PMID 14683620 DOI: 10.1007/S11910-004-0001-0 |
0.312 |
|
| 2004 |
Srinivasan R, Wolfe D, Huang S, Krisky D, Glorioso J. 806. HSV Based Genetic Selection System for Identification of Pain Signaling Regulators Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.845 |
0.623 |
|
| 2004 |
Jiang C, Wechuck JB, Goins WF, Krisky DM, Wolfe DP, Ataai MM, Glorioso JC. 794. Immobilized Cobalt Affinity Chromatography Provides a Novel, Efficient Method for HSV Gene Vector Purification Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.833 |
0.471 |
|
| 2004 |
Li H, Glorioso JC. 653. Activation of an ATM/chk2-Dependent Pathway Is Required for HSV-1 Protein ICp0 Induced G2/M Cell Cycle Arrest Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.599 |
0.45 |
|
| 2004 |
Hong C, Goss JR, Goins WF, Fink DJ, Glorioso JC. 221. Developing HSV-Mediated Gene Therapy Vectors To Adjust the Metabolic Imbalance of A|[beta]| in Alzheimer's Disease|[ast]| Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.163 |
0.321 |
|
| 2004 |
Puskovic V, Wolfe D, Goss JR, Hang S, Glorioso JC, Mata M, Finnk DJ. 220. Prolonged Biologically Active Transgene Expression Driven by HSV Latency Active Promoter 2 (LAP2) in Brain In Vivo Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.162 |
0.388 |
|
| 2004 |
Chattopadhyay M, Wolfe DP, Goins WC, Huang S, Glorioso JC, Mata M, Fink DJ. 219. Prolonged Bioactive Transgene Expression Driven by the HSV Latency Active Promoter 2 (LAP2) in the Peripheral Nervous System Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.161 |
0.31 |
|
| 2004 |
Goss JR, Fetterolf C, Goins W, Wolfe D, Huang S, Krisky D, Glorioso JC, Mata M, Fink DJ. 214. Additive Effects of HSV Vectors Expressing Proenkephalin, Interleukin-4, and Tumor Necrosis Factor Alpha Soluble Receptor To Treat Bone Cancer Pain Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.155 |
0.395 |
|
| 2004 |
Wolfe D, Jun L, Shuanglin H, Shuahua H, Mata M, Glorioso J, Fink D. 213. Peripherally Delivered Glutamic Acid Decarboxylase (GAD) Gene Therapy for Below-Level Spinal Cord Injury Neuropathic Pain Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.154 |
0.355 |
|
| 2004 |
Fradette J, Flanigan R, Krisky DM, Goins WF, Glorioso JC. 164. Secretion of human recombinant factor IX from cells of adipose, myogenic and hepatic origin transduced with replication-defective HSV-1 genomic vectors|[ast]| Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.124 |
0.483 |
|
| 2004 |
Nakano K, Asano R, Tsumoto K, Goin WF, Kumagai I, Cohen JB, Glorioso JC. 63. Re-directed herpes simplex virus infection by a soluble, bi-specific adapter protein for gD in combination with nectin-1 blocking agents Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.05.081 |
0.419 |
|
| 2003 |
Natsume A, Wolfe D, Hu J, Huang S, Puskovic V, Glorioso JC, Fink DJ, Mata M. Enhanced functional recovery after proximal nerve root injury by vector-mediated gene transfer. Experimental Neurology. 184: 878-86. PMID 14769380 DOI: 10.1016/S0014-4886(03)00334-0 |
0.356 |
|
| 2003 |
Mata M, Glorioso JC, Fink DJ. Gene transfer to the nervous system: prospects for novel treatments directed at diseases of the aging nervous system. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 58: M1111-8. PMID 14684708 DOI: 10.1093/Gerona/58.12.M1111 |
0.356 |
|
| 2003 |
Glorioso JC, Mata M, Fink DJ. Exploiting the neurotherapeutic potential of peptides: targeted delivery using HSV vectors. Expert Opinion On Biological Therapy. 3: 1233-9. PMID 14640949 DOI: 10.1517/14712598.3.8.1233 |
0.441 |
|
| 2003 |
Mata M, Glorioso J, Fink DJ. Development of HSV-mediated gene transfer for the treatment of chronic pain. Experimental Neurology. 184: S25-9. PMID 14597322 DOI: 10.1016/S0014-4886(03)00357-1 |
0.327 |
|
| 2003 |
Fink DJ, Glorioso J, Mata M. Therapeutic gene transfer with herpes-based vectors: studies in Parkinson's disease and motor nerve regeneration. Experimental Neurology. 184: S19-24. PMID 14597321 DOI: 10.1016/S0014-4886(03)00358-3 |
0.404 |
|
| 2003 |
Hao S, Mata M, Wolfe D, Huang S, Glorioso JC, Fink DJ. HSV-mediated gene transfer of the glial cell-derived neurotrophic factor provides an antiallodynic effect on neuropathic pain. Molecular Therapy : the Journal of the American Society of Gene Therapy. 8: 367-75. PMID 12946309 DOI: 10.1016/S1525-0016(03)00185-0 |
0.394 |
|
| 2003 |
Fink D, Mata M, Glorioso JC. Cell and gene therapy in the treatment of pain. Advanced Drug Delivery Reviews. 55: 1055-64. PMID 12935944 DOI: 10.1016/S0169-409X(03)00103-0 |
0.363 |
|
| 2003 |
Kohn DB, Sadelain M, Dunbar C, Bodine D, Kiem HP, Candotti F, Tisdale J, Riviére I, Blau CA, Richard RE, Sorrentino B, Nolta J, Malech H, Brenner M, Cornetta K, ... ... Glorioso J, et al. American Society of Gene Therapy (ASGT) ad hoc subcommittee on retroviral-mediated gene transfer to hematopoietic stem cells. Molecular Therapy : the Journal of the American Society of Gene Therapy. 8: 180-7. PMID 12907140 DOI: 10.1016/S1525-0016(03)00212-0 |
0.363 |
|
| 2003 |
Kohn DB, Sadelain M, Glorioso JC. Occurrence of leukaemia following gene therapy of X-linked SCID. Nature Reviews. Cancer. 3: 477-88. PMID 12835668 DOI: 10.1038/Nrc1122 |
0.369 |
|
| 2003 |
Misumi M, Suzuki T, Moriuchi S, Glorioso JC, Bessho M. In vitro thymidine kinase/ganciclovir-based suicide gene therapy using replication defective herpes simplex virus-1 against leukemic B-cell malignancies (MCL, HCL, B-CLL). Leukemia Research. 27: 695-9. PMID 12801527 DOI: 10.1016/S0145-2126(02)00327-2 |
0.459 |
|
| 2003 |
Yao Q, Wang S, Gambotto A, Glorioso JC, Evans CH, Robbins PD, Ghivizzani SC, Oligino TJ. Intra-articular adenoviral-mediated gene transfer of trail induces apoptosis of arthritic rabbit synovium. Gene Therapy. 10: 1055-60. PMID 12776164 DOI: 10.1038/Sj.Gt.3301881 |
0.317 |
|
| 2003 |
Glorioso JC, Mata M, Fink DJ. Therapeutic gene transfer to the nervous system using viral vectors. Journal of Neurovirology. 9: 165-72. PMID 12707847 DOI: 10.1080/13550280390193984 |
0.435 |
|
| 2003 |
Hao S, Mata M, Goins W, Glorioso JC, Fink DJ. Transgene-mediated enkephalin release enhances the effect of morphine and evades tolerance to produce a sustained antiallodynic effect in neuropathic pain. Pain. 102: 135-42. PMID 12620604 DOI: 10.1016/S0304-3959(02)00346-9 |
0.375 |
|
| 2003 |
Burton EA, Hong CS, Glorioso JC. The stable 2.0-kilobase intron of the herpes simplex virus type 1 latency-associated transcript does not function as an antisense repressor of ICP0 in nonneuronal cells. Journal of Virology. 77: 3516-30. PMID 12610127 DOI: 10.1128/Jvi.77.6.3516-3530.2003 |
0.477 |
|
| 2003 |
Chattopadhyay M, Goss J, Lacomis D, Goins WC, Glorioso JC, Mata M, Fink DJ. Protective effect of HSV-mediated gene transfer of nerve growth factor in pyridoxine neuropathy demonstrates functional activity of trkA receptors in large sensory neurons of adult animals. The European Journal of Neuroscience. 17: 732-40. PMID 12603263 DOI: 10.1046/J.1460-9568.2003.02500.X |
0.353 |
|
| 2003 |
Guo HL, Wolfe D, Epperly MW, Huang S, Liu K, Glorioso JC, Greenberger J, Blumberg D. Gene transfer of human manganese superoxide dismutase protects small intestinal villi from radiation injury. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. 7: 229-35; discussion 2. PMID 12600447 DOI: 10.1016/S1091-255X(02)00186-5 |
0.335 |
|
| 2003 |
Burton EA, Huang S, Goins WF, Glorioso JC. Use of the herpes simplex viral genome to construct gene therapy vectors. Methods in Molecular Medicine. 76: 1-31. PMID 12526156 DOI: 10.1385/1-59259-304-6:01 |
0.429 |
|
| 2003 |
Kohn DB, Sadelain M, Glorioso JC. Correction: Occurrence of leukaemia following gene therapy of X-linked SCID Nature Reviews Cancer. 3: 883-883. DOI: 10.1038/Nrc1236 |
0.304 |
|
| 2003 |
Burton EA, Bai Q, Goins WF, Fink DJ, Glorioso JC. Virus-based vectors for gene expression in mammalian cells: Herpes simplex virus New Comprehensive Biochemistry. 38: 27-54. DOI: 10.1016/S0167-7306(03)38003-2 |
0.501 |
|
| 2002 |
Goins WF, Marconi P, Krisky D, Wolfe D, Glorioso JC, Ramakrishnan R, Fink DJ. Construction of replication-defective herpes simplex virus vectors. Current Protocols in Human Genetics / Editorial Board, Jonathan L. Haines ... [Et Al.]. Unit 12.11. PMID 18428322 DOI: 10.1002/0471142905.Hg1211S33 |
0.516 |
|
| 2002 |
Wechuck JB, Ozuer A, Goins WF, Wolfe D, Oligino T, Glorioso JC, Ataai MM. Effect of temperature, medium composition, and cell passage on production of herpes-based viral vectors. Biotechnology and Bioengineering. 79: 112-9. PMID 17590937 DOI: 10.1002/Bit.10310 |
0.409 |
|
| 2002 |
Burton EA, Fink DJ, Glorioso JC. Gene delivery using herpes simplex virus vectors. Dna and Cell Biology. 21: 915-36. PMID 12573050 DOI: 10.1089/104454902762053864 |
0.539 |
|
| 2002 |
Mata M, Glorioso JC, Fink DJ. Targeted gene delivery to the nervous system using herpes simplex virus vectors. Physiology & Behavior. 77: 483-8. PMID 12526987 DOI: 10.1016/S0031-9384(02)00908-3 |
0.465 |
|
| 2002 |
Burton EA, Bai Q, Goins WF, Glorioso JC. Replication-defective genomic herpes simplex vectors: design and production. Current Opinion in Biotechnology. 13: 424-8. PMID 12459332 DOI: 10.1016/S0958-1669(02)00359-2 |
0.47 |
|
| 2002 |
Miura F, Moriuchi S, Maeda M, Sano A, Maruno M, Tsanaclis AM, Marino R, Glorioso JC, Yoshimine T. Sustained release of low-dose ganciclovir from a silicone formulation prolonged the survival of rats with gliosarcomas under herpes simplex virus thymidine kinase suicide gene therapy. Gene Therapy. 9: 1653-8. PMID 12457278 DOI: 10.1038/Sj.Gt.3301860 |
0.367 |
|
| 2002 |
Goss JR, Harley CF, Mata M, O'Malley ME, Goins WF, Hu X, Glorioso JC, Fink DJ. Herpes vector-mediated expression of proenkephalin reduces bone cancer pain. Annals of Neurology. 52: 662-5. PMID 12402268 DOI: 10.1002/Ana.10343 |
0.411 |
|
| 2002 |
Goss JR, Goins WF, Lacomis D, Mata M, Glorioso JC, Fink DJ. Herpes simplex-mediated gene transfer of nerve growth factor protects against peripheral neuropathy in streptozotocin-induced diabetes in the mouse. Diabetes. 51: 2227-32. PMID 12086954 DOI: 10.2337/Diabetes.51.7.2227 |
0.38 |
|
| 2002 |
Chen XP, Mata M, Kelley M, Glorioso JC, Fink DJ. The relationship of herpes simplex virus latency associated transcript expression to genome copy number: a quantitative study using laser capture microdissection. Journal of Neurovirology. 8: 204-10. PMID 12053275 DOI: 10.1080/13550280290049642 |
0.355 |
|
| 2002 |
Ozuer A, Wechuck JB, Russell B, Wolfe D, Goins WF, Glorioso JC, Ataai MM. Evaluation of infection parameters in the production of replication-defective HSV-1 viral vectors. Biotechnology Progress. 18: 476-82. PMID 12052062 DOI: 10.1021/Bp010176K |
0.493 |
|
| 2002 |
Goins WF, Krisky DM, Wolfe DP, Fink DJ, Glorioso JC. Development of replication-defective herpes simplex virus vectors. Methods in Molecular Medicine. 69: 481-507. PMID 11987796 |
0.339 |
|
| 2002 |
Moriuchi S, Wolfe D, Tamura M, Yoshimine T, Miura F, Cohen JB, Glorioso JC. Double suicide gene therapy using a replication defective herpes simplex virus vector reveals reciprocal interference in a malignant glioma model. Gene Therapy. 9: 584-91. PMID 11973634 DOI: 10.1038/Sj.Gt.3301693 |
0.456 |
|
| 2002 |
Glorioso JC, Fink DJ. Use of HSV vectors to modify the nervous system. Current Opinion in Drug Discovery & Development. 5: 289-95. PMID 11926135 |
0.354 |
|
| 2002 |
Iwai M, Harada Y, Ishii M, Kashima K, Mazda O, Tamura M, Wolfe D, Goin WF, Glorioso JC. Suicide gene therapy of human hepatoma and its peritonitis carcinomatosis by a vector of replicative-deficient herpes simplex virus. Biochemical and Biophysical Research Communications. 291: 855-60. PMID 11866443 DOI: 10.1006/Bbrc.2002.6524 |
0.524 |
|
| 2002 |
Natsume A, Mata M, Wolfe D, Oligino T, Goss J, Huang S, Glorioso J, Fink DJ. Bcl-2 and GDNF delivered by HSV-mediated gene transfer after spinal root avulsion provide a synergistic effect. Journal of Neurotrauma. 19: 61-8. PMID 11852979 DOI: 10.1089/089771502753460240 |
0.394 |
|
| 2002 |
Ozuer A, Wechuck JB, Goins WF, Wolfe D, Glorioso JC, Ataai MM. Effect of genetic background and culture conditions on the production of herpesvirus-based gene therapy vectors. Biotechnology and Bioengineering. 77: 685-92. PMID 11807764 DOI: 10.1002/Bit.10162 |
0.386 |
|
| 2002 |
Chattopadhyay M, Wolfe D, Huang S, Goss J, Glorioso JC, Mata M, Fink DJ. In vivo gene therapy for pyridoxine-induced neuropathy by herpes simplex virus-mediated gene transfer of neurotrophin-3. Annals of Neurology. 51: 19-27. PMID 11782980 DOI: 10.1002/Ana.10061 |
0.462 |
|
| 2001 |
Burton EA, Bai Q, Goins WF, Glorioso JC. Targeting gene expression using HSV vectors. Advanced Drug Delivery Reviews. 53: 155-70. PMID 11731025 DOI: 10.1016/S0169-409X(01)00226-5 |
0.508 |
|
| 2001 |
Burton EA, Wechuck JB, Wendell SK, Goins WF, Fink DJ, Glorioso JC. Multiple applications for replication-defective herpes simplex virus vectors. Stem Cells (Dayton, Ohio). 19: 358-77. PMID 11553845 DOI: 10.1634/Stemcells.19-5-358 |
0.528 |
|
| 2001 |
Ruffini F, Furlan R, Poliani PL, Brambilla E, Marconi PC, Bergami A, Desina G, Glorioso JC, Comi G, Martino G. Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice. Gene Therapy. 8: 1207-13. PMID 11509953 DOI: 10.1038/Sj.Gt.3301523 |
0.383 |
|
| 2001 |
Mårdberg K, Trybala E, Glorioso JC, Bergström T. Mutational analysis of the major heparan sulfate-binding domain of herpes simplex virus type 1 glycoprotein C. The Journal of General Virology. 82: 1941-50. PMID 11458001 DOI: 10.1099/0022-1317-82-8-1941 |
0.354 |
|
| 2001 |
Furlan R, Poliani PL, Marconi PC, Bergami A, Ruffini F, Adorini L, Glorioso JC, Comi G, Martino G. Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice. Gene Therapy. 8: 13-9. PMID 11402297 DOI: 10.1038/Sj.Gt.3301357 |
0.319 |
|
| 2001 |
Poliani PL, Brok H, Furlan R, Ruffini F, Bergami A, Desina G, Marconi PC, Rovaris M, Uccelli A, Glorioso JC, Penna G, Adorini L, Comi G, 't Hart B, Martino G. Delivery to the central nervous system of a nonreplicative herpes simplex type 1 vector engineered with the interleukin 4 gene protects rhesus monkeys from hyperacute autoimmune encephalomyelitis. Human Gene Therapy. 12: 905-20. PMID 11387056 DOI: 10.1089/104303401750195872 |
0.397 |
|
| 2001 |
Yoshimura N, Franks ME, Sasaki K, Goins WF, Goss J, Yokoyama T, Fraser MO, Seki S, Fink J, Glorioso J, de Groat WC, Chancellor MB. Gene therapy of bladder pain with herpes simplex virus (HSV) vectors expressing preproenkephalin (PPE). Urology. 57: 116. PMID 11378092 DOI: 10.1016/S0090-4295(01)01060-3 |
0.473 |
|
| 2001 |
Natsume A, Mata M, Goss J, Huang S, Wolfe D, Oligino T, Glorioso J, Fink DJ. Bcl-2 and GDNF delivered by HSV-mediated gene transfer act additively to protect dopaminergic neurons from 6-OHDA-induced degeneration. Experimental Neurology. 169: 231-238. PMID 11358438 DOI: 10.1006/Exnr.2001.7671 |
0.422 |
|
| 2001 |
Goins WF, Yoshimura N, Phelan MW, Yokoyama T, Fraser MO, Ozawa H, Bennett N JR, de Groat WC, Glorioso JC, Chancellor MB. Herpes simplex virus mediated nerve growth factor expression in bladder and afferent neurons: potential treatment for diabetic bladder dysfunction. The Journal of Urology. 165: 1748-54. PMID 11342969 DOI: 10.1016/S0022-5347(05)66407-5 |
0.403 |
|
| 2001 |
Goss JR, Mata M, Goins WF, Wu HH, Glorioso JC, Fink DJ. Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion. Gene Therapy. 8: 551-6. PMID 11319622 DOI: 10.1038/Sj.Gt.3301430 |
0.469 |
|
| 2001 |
Burton EA, Glorioso JC. Multi-modal combination gene therapy for malignant glioma using replication-defective HSV vectors. Drug Discovery Today. 6: 347-356. PMID 11267921 DOI: 10.1016/S1359-6446(01)01713-5 |
0.48 |
|
| 2001 |
Yamada M, Natsume A, Mata M, Oligino T, Goss J, Glorioso J, Fink DJ. Herpes simplex virus vector-mediated expression of Bcl-2 protects spinal motor neurons from degeneration following root avulsion. Experimental Neurology. 168: 225-230. PMID 11259110 DOI: 10.1006/Exnr.2000.7597 |
0.362 |
|
| 2001 |
Ghivizzani SC, Oligino TJ, Glorioso JC, Robbins PD, Evans CH. Direct gene delivery strategies for the treatment of rheumatoid arthritis. Drug Discovery Today. 6: 259-267. PMID 11182599 DOI: 10.1016/S1359-6446(01)01685-3 |
0.471 |
|
| 2001 |
Wolfe D, Goins WF, Kaplan TJ, Capuano SV, Fradette J, Murphey-Corb M, Robbins PD, Cohen JB, Glorioso JC. Herpesvirus-mediated systemic delivery of nerve growth factor. Molecular Therapy : the Journal of the American Society of Gene Therapy. 3: 61-9. PMID 11162312 DOI: 10.1006/Mthe.2000.0225 |
0.406 |
|
| 2001 |
Kay MA, Glorioso JC, Naldini L. Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nature Medicine. 7: 33-40. PMID 11135613 DOI: 10.1038/83324 |
0.447 |
|
| 2001 |
Oligino T, Yao Q, Wang S, Glorioso J, Evans CH, Ghivizzani S, Takate R, Barton R, Robbins P. Induction of synovial apoptosis by gene transfer and peptide mediated protein transduction Arthritis Research & Therapy. 3: 27. DOI: 10.1186/Ar353 |
0.333 |
|
| 2001 |
Niranjan A, Tamura M, Lunsford LD, Kondziolka D, Fellows W, Glorioso JC. 722 Connexin and TNF-α-enhanced-Radiosurgery in Combination with Herpes Simplex Virus-mediated Suicide Gene Therapy Improves Survival in 9L Rat Gliosarcoma Model Neurosurgery. 49: 512-513. DOI: 10.1097/00006123-200108000-00086 |
0.387 |
|
| 2000 |
Mi Z, Ghivizzani SC, Lechman ER, Jaffurs D, Glorioso JC, Evans CH, Robbins PD. Adenovirus-mediated gene transfer of insulin-like growth factor 1 stimulates proteoglycan synthesis in rabbit joints. Arthritis and Rheumatism. 43: 2563-70. PMID 11083281 DOI: 10.1002/1529-0131(200011)43:11<2563::Aid-Anr25>3.0.Co;2-8 |
0.302 |
|
| 2000 |
Rouse RJ, Seifried W, Mistry SK, Goins WF, Glorioso JC. Herpes simplex virus-enhanced cationic lipid/DNA-mediated transfection. Biotechniques. 29: 810-4. PMID 11056812 DOI: 10.2144/00294St08 |
0.513 |
|
| 2000 |
Glorioso JC. Perspectives on viral vector design and applications. Advances in Virus Research. 55: 403-7. PMID 11050948 DOI: 10.1016/S0065-3527(00)55009-X |
0.509 |
|
| 2000 |
Ghivizzani SC, Oligino TJ, Glorioso JC, Robbins PD, Evans CH. Gene therapy approaches for treating rheumatoid arthritis. Clinical Orthopaedics and Related Research. S288-99. PMID 11039782 DOI: 10.1097/00003086-200010001-00038 |
0.442 |
|
| 2000 |
Chen Xp, Li J, Mata M, Goss J, Wolfe D, Glorioso JC, Fink DJ. Herpes simplex virus type 1 ICP0 protein does not accumulate in the nucleus of primary neurons in culture. Journal of Virology. 74: 10132-41. PMID 11024142 DOI: 10.1128/Jvi.74.21.10132-10141.2000 |
0.463 |
|
| 2000 |
Moriuchi S, Krisky DM, Marconi PC, Tamura M, Shimizu K, Yoshimine T, Cohen JB, Glorioso JC. HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma. Gene Therapy. 7: 1483-90. PMID 11001368 DOI: 10.1038/Sj.Gt.3301265 |
0.504 |
|
| 2000 |
Niranjan A, Moriuchi S, Lunsford LD, Kondziolka D, Flickinger JC, Fellows W, Rajendiran S, Tamura M, Cohen JB, Glorioso JC. Effective treatment of experimental glioblastoma by HSV vector-mediated TNF alpha and HSV-tk gene transfer in combination with radiosurgery and ganciclovir administration. Molecular Therapy : the Journal of the American Society of Gene Therapy. 2: 114-20. PMID 10947938 DOI: 10.1006/Mthe.2000.0101 |
0.444 |
|
| 2000 |
Aguilar LK, Aguilar-Cordova E, Ando D, Armendariz-Borunda J, Burd PR, Butler EB, Carter B, Chiang YL, Glorioso JC, Henderson DR, Jolly D, McKenny GP, Nemunaitis J, Rives M, Scherer S, et al. A prescription for gene therapy: The first cabo gene therapy working group Molecular Therapy. 1: 385-388. PMID 10933958 DOI: 10.1006/Mthe.2000.0070 |
0.315 |
|
| 2000 |
Marconi P, Tamura M, Moriuchi S, Krisky DM, Niranjan A, Goins WF, Cohen JB, Glorioso JC. Connexin 43-enhanced suicide gene therapy using herpesviral vectors. Molecular Therapy : the Journal of the American Society of Gene Therapy. 1: 71-81. PMID 10933914 DOI: 10.1006/Mthe.1999.0008 |
0.461 |
|
| 2000 |
Martino G, Poliani PL, Furlan R, Marconi P, Glorioso JC, Adorini L, Comi G. Cytokine therapy in immune-mediated demyelinating diseases of the central nervous system: a novel gene therapy approach. Journal of Neuroimmunology. 107: 184-90. PMID 10854655 DOI: 10.1016/S0165-5728(00)00236-8 |
0.37 |
|
| 2000 |
Wechuck JB, Goins WF, Glorioso JC, Ataai MM. Effect of protease inhibitors on yield of HSV-1-based viral vectors. Biotechnology Progress. 16: 493-6. PMID 10835254 DOI: 10.1021/Bp000016T |
0.447 |
|
| 2000 |
Simonato M, Manservigi R, Marconi P, Glorioso J. Gene transfer into neurones for the molecular analysis of behaviour: Focus on herpes simplex vectors Trends in Neurosciences. 23: 183-190. PMID 10782119 DOI: 10.1016/S0166-2236(99)01539-8 |
0.484 |
|
| 2000 |
Gómez-Navarro J, Contreras JL, Arafat W, Jiang XL, Krisky D, Oligino T, Marconi P, Hubbard B, Glorioso JC, Curiel DT, Thomas JM. Genetically modified CD34+ cells as cellular vehicles for gene delivery into areas of angiogenesis in a rhesus model. Gene Therapy. 7: 43-52. PMID 10680015 DOI: 10.1038/Sj.Gt.3301054 |
0.365 |
|
| 2000 |
Fink DJ, DeLuca NA, Yamada M, Wolfe DP, Glorioso JC. Design and application of HSV vectors for neuroprotection. Gene Therapy. 7: 115-9. PMID 10673716 DOI: 10.1038/Sj.Gt.3301118 |
0.465 |
|
| 2000 |
Anderson DB, Laquerre S, Ghosh K, Ghosh HP, Goins WF, Cohen JB, Glorioso JC. Pseudotyping of glycoprotein D-deficient herpes simplex virus type 1 with vesicular stomatitis virus glycoprotein G enables mutant virus attachment and entry. Journal of Virology. 74: 2481-7. PMID 10666285 DOI: 10.1128/Jvi.74.5.2481-2487.2000 |
0.493 |
|
| 1999 |
Akkaraju GR, Huard J, Hoffman EP, Goins WF, Pruchnic R, Watkins SC, Cohen JB, Glorioso JC. Herpes simplex virus vector-mediated dystrophin gene transfer and expression in MDX mouse skeletal muscle. The Journal of Gene Medicine. 1: 280-9. PMID 10738561 DOI: 10.1002/(Sici)1521-2254(199907/08)1:4<280::Aid-Jgm45>3.0.Co;2-L |
0.475 |
|
| 1999 |
Oligino T, Ghivizzani SC, Wolfe D, Lechman ER, Krisky D, Mi Z, Evans CH, Robbins PD, Glorioso JC. Intra-articular delivery of a herpes simplex virus IL-1Ra gene vector reduces inflammation in a rabbit model of arthritis Gene Therapy. 6: 1713-1720. PMID 10516720 DOI: 10.1038/Sj.Gt.3301014 |
0.444 |
|
| 1999 |
Marconi P, Simonato M, Zucchini S, Bregola G, Argnani R, Krisky D, Glorioso JC, Manservigi R. Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo. Gene Therapy. 6: 904-12. PMID 10505116 DOI: 10.1038/Sj.Gt.3300882 |
0.444 |
|
| 1999 |
Wolfe D, Goins WF, Yamada M, Moriuchi S, Krisky DM, Oligino TJ, Marconi PC, Fink DJ, Glorioso JC. Engineering herpes simplex virus vectors for CNS applications. Experimental Neurology. 159: 34-46. PMID 10486173 DOI: 10.1006/Exnr.1999.7158 |
0.415 |
|
| 1999 |
Simonato M, Marconi P, Glorioso J, Manservigi R. Molecular analysis of behavior by gene transfer into neurons with herpes simplex vectors Brain Research. 835: 37-45. PMID 10448194 DOI: 10.1016/S0006-8993(99)01245-7 |
0.425 |
|
| 1999 |
Alvira MR, Goins WF, Cohen JB, Glorioso JC. Genetic studies exposing the splicing events involved in herpes simplex virus type 1 latency-associated transcript production during lytic and latent infection. Journal of Virology. 73: 3866-76. PMID 10196281 DOI: 10.1128/Jvi.73.5.3866-3876.1999 |
0.427 |
|
| 1999 |
Yamada M, Oligino T, Mata M, Goss JR, Glorioso JC, Fink DJ. Herpes simplex virus vector-mediated expression of Bcl-2 prevents 6-hydroxydopamine-induced degeneration of neurons in the substantia nigra in vivo. Proceedings of the National Academy of Sciences of the United States of America. 96: 4078-83. PMID 10097166 DOI: 10.1073/Pnas.96.7.4078 |
0.394 |
|
| 1999 |
Wilson SP, Yeomans DC, Bender MA, Lu Y, Goins WF, Glorioso JC. Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus. Proceedings of the National Academy of Sciences of the United States of America. 96: 3211-6. PMID 10077663 DOI: 10.1073/Pnas.96.6.3211 |
0.467 |
|
| 1999 |
Goins WF, Lee KA, Cavalcoli JD, O'Malley ME, DeKosky ST, Fink DJ, Glorioso JC. Herpes simplex virus type 1 vector-mediated expression of nerve growth factor protects dorsal root ganglion neurons from peroxide toxicity. Journal of Virology. 73: 519-32. PMID 9847358 DOI: 10.1128/Jvi.73.1.519-532.1999 |
0.412 |
|
| 1999 |
Laquerre S, Goins WF, Moriuchi S, Oligino TJ, Krisky DM, Marconi P, Soares MK, Cohen JB, Glorioso JC, Fink DJ. 8 Gene-transfer Tool: Herpes Simplex Virus Vectors Cold Spring Harbor Monograph Archive. 36: 173-208. DOI: 10.1101/087969528.36.173 |
0.519 |
|
| 1999 |
Yoshimura N, Yokoyama T, Fraser MO, Ozawa H, Bennett N, Goins WF, Glorioso JC, Groat WCd, Chancellor MB. Nerve Growth Factor (Ngf) Gene Therapy Using Replication Defective Herpes Simplex Virus (Hsv) Vectors For Diabetic Bladder Dysfunction The Journal of Urology. 274. DOI: 10.1097/00005392-199904020-00099 |
0.415 |
|
| 1999 |
Chancellor MB, Goins WF, Yoshimura N, Yokoyama T, Fraser MO, Bennett NE, deGroat WC, Glorioso JC. Bladder Gene Therapy With Nerve Growth Factor (Ngf) Using Herpes Simplex Virus (Hsv) Vectors The Journal of Urology. 253. DOI: 10.1097/00005392-199904020-00016 |
0.421 |
|
| 1999 |
Lemoine NR, Glorioso JC. Gene therapy for the millenium: In with the new Gene Therapy. 6: 1199. DOI: 10.1038/Sj.Gt.3300984 |
0.314 |
|
| 1999 |
Glorioso J. Handling herpesvirus: Herpes Simplex Virus Protocols (Methods in Molecular Medicine series), edited by S.M. Brown and A.R. MacLean Trends in Microbiology. 7: 51-52. DOI: 10.1016/S0966-842X(98)01415-2 |
0.317 |
|
| 1998 |
Krisky DM, Wolfe D, Goins WF, Marconi PC, Ramakrishnan R, Mata M, Rouse RJ, Fink DJ, Glorioso JC. Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons. Gene Therapy. 5: 1593-603. PMID 10023438 DOI: 10.1038/Sj.Gt.3300766 |
0.485 |
|
| 1998 |
Krisky DM, Marconi PC, Oligino TJ, Rouse RJ, Fink DJ, Cohen JB, Watkins SC, Glorioso JC. Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applications. Gene Therapy. 5: 1517-30. PMID 9930305 DOI: 10.1038/Sj.Gt.3300755 |
0.522 |
|
| 1998 |
Suzuki T, Piche A, Kasono K, Xiang J, Gomez-Navarro J, Moriuchi S, Krisky DM, Oligino T, Glorioso JC, Curiel TJ, Curiel DT. Efficient gene delivery into epstein-barr virus (EBV)-transformed human B cells mediated by replication-defective herpes simplex virus-1 (HSV-1): A gene therapy model for EBV-related B cell malignancy. Biochemical and Biophysical Research Communications. 252: 686-90. PMID 9837767 DOI: 10.1006/Bbrc.1998.9685 |
0.494 |
|
| 1998 |
Wang M, Rancourt C, Navarro JG, Krisky D, Marconi P, Oligino T, Alvarez RD, Siegal GP, Glorioso JC, Curiel DT. High-efficacy thymidine kinase gene transfer to ovarian cancer cell lines mediated by herpes simplex virus type 1 vector. Gynecologic Oncology. 71: 278-87. PMID 9826472 DOI: 10.1006/Gyno.1998.5132 |
0.478 |
|
| 1998 |
Laquerre S, Anderson DB, Stolz DB, Glorioso JC. Recombinant herpes simplex virus type 1 engineered for targeted binding to erythropoietin receptor-bearing cells. Journal of Virology. 72: 9683-97. PMID 9811702 DOI: 10.1128/Jvi.72.12.9683-9697.1998 |
0.5 |
|
| 1998 |
van Deutekom JC, Floyd SS, Booth DK, Oligino T, Krisky D, Marconi P, Glorioso JC, Huard J. Implications of maturation for viral gene delivery to skeletal muscle. Neuromuscular Disorders : Nmd. 8: 135-48. PMID 9631393 DOI: 10.1016/S0960-8966(98)00019-4 |
0.352 |
|
| 1998 |
Laquerre S, Argnani R, Anderson DB, Zucchini S, Manservigi R, Glorioso JC. Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread. Journal of Virology. 72: 6119-30. PMID 9621076 DOI: 10.1128/Jvi.72.7.6119-6130.1998 |
0.472 |
|
| 1998 |
Oligino T, Poliani PL, Wang Y, Tsai SY, O'Malley BW, Fink DJ, Glorioso JC. Drug inducible transgene expression in brain using a herpes simplex virus vector. Gene Therapy. 5: 491-6. PMID 9614573 DOI: 10.1038/sj.gt.3300612 |
0.333 |
|
| 1998 |
Kang W, Wilson MA, Bender MA, Glorioso JC, Wilson SP. Herpes virus-mediated preproenkephalin gene transfer to the amygdala is antinociceptive. Brain Research. 792: 133-5. PMID 9593860 DOI: 10.1016/S0006-8993(98)00194-2 |
0.454 |
|
| 1998 |
Laquerre S, Anderson DB, Argnani R, Glorioso JC. Herpes simplex virus type 1 glycoprotein B requires a cysteine residue at position 633 for folding, processing, and incorporation into mature infectious virus particles. Journal of Virology. 72: 4940-9. PMID 9573262 DOI: 10.1128/Jvi.72.6.4940-4949.1998 |
0.414 |
|
| 1998 |
Kuklin NA, Daheshia M, Marconi PC, Krisky DM, Rouse RJ, Glorioso JC, Manican E, Rouse BT. Modulation of mucosal and systemic immunity by enteric administration of nonreplicating herpes simplex virus expressing cytokines. Virology. 240: 245-53. PMID 9454698 DOI: 10.1006/Viro.1997.8926 |
0.405 |
|
| 1998 |
Gómez-Navarro J, Contreras J, Bilbao G, Asiedu C, Huang Z, Salzman D, Siegal GP, Thomas F, Thomas JM, Glorioso JC, Curiel DT. GENETICALLY MODIFIED CD34+ CELLS AS VECTORS FOR IN VIVO GENE DELIVERY TO AREAS OF ANGIOGENESIS. Transplantation. 65: 155. DOI: 10.1097/00007890-199805131-00305 |
0.329 |
|
| 1998 |
Gómez-Navarro J, Contreras J, Bilbao G, Asiedu C, Huang Z, Salzman D, Siegal GP, Thomas JM, Glorioso JC, Curiel DT. HIGHLY EFFICIENT, NONTOXIC GENETIC MODIFICATION OF HUMAN AND NON-HUMAN PRIMATE CD34+ STEM CELLS WITH A REPLICATION-DEFICIENT HERPES SIMPLEX VIRUS Transplantation. 65: 121. DOI: 10.1097/00007890-199805131-00171 |
0.349 |
|
| 1998 |
Moriuchi S, Oligino T, Krisky D, Marconi P, Fink D, Glorioso JC, Joe J. Enhanced killing of human glioblastoma U-87MG tumors by TNF-α, connexin-43 and HSV-TK combination gene therapy Journal of Neuroimmunology. 90: 101. DOI: 10.1016/S0165-5728(98)91780-5 |
0.328 |
|
| 1997 |
Krisky D, Marconi P, Goins WF, Glorioso JC. Development of replication-defective herpes simplex virus vectors. Methods in Molecular Medicine. 7: 79-102. PMID 24493419 DOI: 10.1385/0-89603-484-4:79 |
0.437 |
|
| 1997 |
Evans C, Goins WF, Schmidt MC, Robbins PD, Ghivizzani SC, Oligino T, Marconi P, Krisky D, Glorioso JC. Progress in development of herpes simplex virus gene vectors for treatment of rheumatoid arthritis. Advanced Drug Delivery Reviews. 27: 41-57. PMID 10837550 DOI: 10.1016/S0169-409X(97)00021-5 |
0.476 |
|
| 1997 |
Krisky DM, Marconi PC, Oligino T, Rouse RJ, Fink DJ, Glorioso JC. Rapid method for construction of recombinant HSV gene transfer vectors. Gene Therapy. 4: 1120-5. PMID 9415320 DOI: 10.1038/Sj.Gt.3300497 |
0.479 |
|
| 1997 |
Rasty S, Poliani PL, Fink DJ, Glorioso JC. Deletion of the S component inverted repeat sequence c' and the nonessential genes U(S)1 through U(S)5 from the herpes simplex virus type 1 genome substantially impairs productive viral infection in cell culture and pathogenesis in the rat central nervous system. Journal of Neurovirology. 3: 247-64. PMID 9291233 DOI: 10.3109/13550289709029466 |
0.491 |
|
| 1997 |
Huard J, Krisky D, Oligino T, Marconi P, Day CS, Watkins SC, Glorioso JC. Gene transfer to muscle using herpes simplex virus-based vectors. Neuromuscular Disorders : Nmd. 7: 299-313. PMID 9267843 DOI: 10.1016/S0960-8966(97)00054-0 |
0.415 |
|
| 1997 |
Glorioso JC, Goins WF, Schmidt MC, Oligino T, Krisky DM, Marconi PC, Cavalcoli JD, Ramakrishnan R, Poliani PL, Fink DJ. Engineering herpes simplex virus vectors for human gene therapy. Advances in Pharmacology (San Diego, Calif.). 40: 103-36. PMID 9217925 DOI: 10.1016/S1054-3589(08)60139-8 |
0.547 |
|
| 1997 |
Goins WF, Krisky D, Marconi P, Oligino T, Ramakrishnan R, Poliani PL, Fink DJ, Glorioso JC. Herpes simplex virus vectors for gene transfer to the nervous system. Journal of Neurovirology. 3: S80-8. PMID 9179803 |
0.427 |
|
| 1997 |
Fink DJ, Poliani PL, Oligino T, Krisky DM, Goins WF, Glorioso JC. Development of an HSV-based vector for the treatment of Parkinson's disease. Experimental Neurology. 144: 103-21. PMID 9126159 DOI: 10.1006/Exnr.1996.6395 |
0.468 |
|
| 1997 |
Fink DJ, Glorioso JC. Engineering herpes simplex virus vectors for gene transfer to neurons. Nature Medicine. 3: 357-9. PMID 9055868 DOI: 10.1038/nm0397-357 |
0.399 |
|
| 1997 |
Huard J, Akkaraju G, Watkins SC, Pike-Cavalcoli M, Glorioso JC. LacZ gene transfer to skeletal muscle using a replication-defective herpes simplex virus type 1 mutant vector. Human Gene Therapy. 8: 439-52. PMID 9054519 DOI: 10.1089/Hum.1997.8.4-439 |
0.478 |
|
| 1997 |
Feero WG, Rosenblatt JD, Huard J, Watkins SC, Epperly M, Clemens PR, Kochanek S, Glorioso JC, Partridge TA, Hoffman EP. Viral gene delivery to skeletal muscle: insights on maturation-dependent loss of fiber infectivity for adenovirus and herpes simplex type 1 viral vectors. Human Gene Therapy. 8: 371-80. PMID 9054512 DOI: 10.1089/Hum.1997.8.4-371 |
0.343 |
|
| 1996 |
Oligino T, Poliani PL, Marconi P, Bender MA, Schmidt MC, Fink DJ, Glorioso JC. In vivo transgene activation from an HSV-based gene therapy vector by GAL4:vp16. Gene Therapy. 3: 892-9. PMID 8908503 |
0.431 |
|
| 1996 |
Huard J, Feero WG, Watkins SC, Hoffman EP, Rosenblatt DJ, Glorioso JC. The basal lamina is a physical barrier to herpes simplex virus-mediated gene delivery to mature muscle fibers. Journal of Virology. 70: 8117-23. PMID 8892937 DOI: 10.1128/Jvi.70.11.8117-8123.1996 |
0.408 |
|
| 1996 |
Marconi P, Krisky D, Oligino T, Poliani PL, Ramakrishnan R, Goins WF, Fink DJ, Glorioso JC. Replication-defective herpes simplex virus vectors for gene transfer in vivo. Proceedings of the National Academy of Sciences of the United States of America. 93: 11319-20. PMID 8876133 DOI: 10.1073/Pnas.93.21.11319 |
0.535 |
|
| 1996 |
Fink DJ, DeLuca NA, Goins WF, Glorioso JC. Gene transfer to neurons using herpes simplex virus-based vectors. Annual Review of Neuroscience. 19: 265-87. PMID 8833444 DOI: 10.1146/Annurev.Ne.19.030196.001405 |
0.484 |
|
| 1996 |
Soares K, Hwang DY, Ramakrishnan R, Schmidt MC, Fink DJ, Glorioso JC. cis-acting elements involved in transcriptional regulation of the herpes simplex virus type 1 latency-associated promoter 1 (LAP1) in vitro and in vivo. Journal of Virology. 70: 5384-94. PMID 8764049 DOI: 10.1128/Jvi.70.8.5384-5394.1996 |
0.339 |
|
| 1996 |
Ramakrishnan R, Poliani PL, Levine M, Glorioso JC, Fink DJ. Detection of herpes simplex virus type 1 latency-associated transcript expression in trigeminal ganglia by in situ reverse transcriptase PCR. Journal of Virology. 70: 6519-23. PMID 8709293 DOI: 10.1128/Jvi.70.9.6519-6523.1996 |
0.423 |
|
| 1996 |
Rasty S, Thatikunta P, Gordon J, Khalili K, Amini S, Glorioso JC. Human immunodeficiency virus tat gene transfer to the murine central nervous system using a replication-defective herpes simplex virus vector stimulates transforming growth factor beta 1 gene expression. Proceedings of the National Academy of Sciences of the United States of America. 93: 6073-8. PMID 8650221 DOI: 10.1073/Pnas.93.12.6073 |
0.412 |
|
| 1996 |
Laquerre S, Person S, Glorioso JC. Glycoprotein B of herpes simplex virus type 1 oligomerizes through the intermolecular interaction of a 28-amino-acid domain. Journal of Virology. 70: 1640-50. PMID 8627685 DOI: 10.1128/Jvi.70.3.1640-1650.1996 |
0.353 |
|
| 1995 |
Fink DJ, Ramakrishnan R, Marconi P, Goins WF, Holland TC, Glorioso JC. Advances in the development of herpes simplex virus-based gene transfer vectors for the nervous system. Clinical Neuroscience (New York, N.Y.). 3: 284-91. PMID 8914795 |
0.409 |
|
| 1995 |
Glorioso JC, DeLuca NA, Fink DJ. Development and application of herpes simplex virus vectors for human gene therapy. Annual Review of Microbiology. 49: 675-710. PMID 8561476 DOI: 10.1146/Annurev.Mi.49.100195.003331 |
0.468 |
|
| 1995 |
Glorioso JC, Bender MA, Goins WF, Fink DJ, DeLuca N. HSV as a gene transfer vector for the nervous system. Molecular Biotechnology. 4: 87-99. PMID 8521042 DOI: 10.1007/Bf02907473 |
0.514 |
|
| 1995 |
Mester JC, Pitha PM, Glorioso JC. Antiviral activity of herpes simplex virus vectors expressing murine alpha 1-interferon. Gene Therapy. 2: 187-96. PMID 7614249 |
0.361 |
|
| 1995 |
Huard J, Goins WF, Glorioso JC. Herpes simplex virus type 1 vector mediated gene transfer to muscle. Gene Therapy. 2: 385-92. PMID 7584113 |
0.393 |
|
| 1995 |
Chen X, Schmidt MC, Goins WF, Glorioso JC. Two herpes simplex virus type 1 latency-active promoters differ in their contributions to latency-associated transcript expression during lytic and latent infections. Journal of Virology. 69: 7899-908. PMID 7494302 DOI: 10.1128/Jvi.69.12.7899-7908.1995 |
0.481 |
|
| 1994 |
Glorioso JC, Goins WF, DeLuca N, Fink DJ. Development of herpes simplex virus as a gene transfer vector for the nervous system. Gene Therapy. 1: S39. PMID 8542392 |
0.377 |
|
| 1994 |
Glorioso JC, Goins WF, Meaney CA, Fink DJ, DeLuca NA. Gene transfer to brain using herpes simplex virus vectors. Annals of Neurology. 35: S28-34. PMID 8185293 DOI: 10.1002/Ana.410350710 |
0.505 |
|
| 1994 |
Goins WF, Sternberg LR, Croen KD, Krause PR, Hendricks RL, Fink DJ, Straus SE, Levine M, Glorioso JC. A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats. Journal of Virology. 68: 2239-52. PMID 8139009 DOI: 10.1128/Jvi.68.4.2239-2252.1994 |
0.395 |
|
| 1994 |
Ramakrishnan R, Fink DJ, Jiang G, Desai P, Glorioso JC, Levine M. Competitive quantitative PCR analysis of herpes simplex virus type 1 DNA and latency-associated transcript RNA in latently infected cells of the rat brain. Journal of Virology. 68: 1864-73. PMID 8107247 DOI: 10.1128/Jvi.68.3.1864-1873.1994 |
0.434 |
|
| 1994 |
Desai P, Homa FL, Person S, Glorioso JC. A genetic selection method for the transfer of HSV-1 glycoprotein B mutations from plasmid to the viral genome: preliminary characterization of transdominance and entry kinetics of mutant viruses. Virology. 204: 312-22. PMID 8091662 DOI: 10.1006/Viro.1994.1536 |
0.483 |
|
| 1994 |
Glorioso JC, Goins WF, Fink DJ, DeLuca NA. Herpes simplex virus vectors and gene transfer to brain. Developments in Biological Standardization. 82: 79-87. PMID 7958486 |
0.396 |
|
| 1994 |
Trybala E, Bergström T, Svennerholm B, Jeansson S, Glorioso JC, Olofsson S. Localization of a functional site on herpes simplex virus type 1 glycoprotein C involved in binding to cell surface heparan sulphate. The Journal of General Virology. 75: 743-52. PMID 7512117 DOI: 10.1099/0022-1317-75-4-743 |
0.375 |
|
| 1993 |
Desai P, Ramakrishnan R, Lin ZW, Osak B, Glorioso JC, Levine M. The RR1 gene of herpes simplex virus type 1 is uniquely trans activated by ICP0 during infection. Journal of Virology. 67: 6125-35. PMID 8396674 DOI: 10.1128/Jvi.67.10.6125-6135.1993 |
0.329 |
|
| 1993 |
Oyan AM, Dolter KE, Langeland N, Goins WF, Glorioso JC, Haarr L, Crumpacker CS. Resistance of herpes simplex virus type 2 to neomycin maps to the N-terminal portion of glycoprotein C. Journal of Virology. 67: 2434-41. PMID 8386261 DOI: 10.1128/Jvi.67.5.2434-2441.1993 |
0.462 |
|
| 1993 |
Gage PJ, Levine M, Glorioso JC. Syncytium-inducing mutations localize to two discrete regions within the cytoplasmic domain of herpes simplex virus type 1 glycoprotein B. Journal of Virology. 67: 2191-201. PMID 8383236 DOI: 10.1128/Jvi.67.4.2191-2201.1993 |
0.346 |
|
| 1993 |
Desai P, DeLuca NA, Glorioso JC, Person S. Mutations in herpes simplex virus type 1 genes encoding VP5 and VP23 abrogate capsid formation and cleavage of replicated DNA. Journal of Virology. 67: 1357-64. PMID 8382300 DOI: 10.1128/Jvi.67.3.1357-1364.1993 |
0.464 |
|
| 1993 |
Bandara G, Mueller GM, Galea-Lauri J, Tindal MH, Georgescu HI, Suchanek MK, Hung GL, Glorioso JC, Robbins PD, Evans CH. Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer. Proceedings of the National Academy of Sciences of the United States of America. 90: 10764-8. PMID 8248169 DOI: 10.1073/Pnas.90.22.10764 |
0.386 |
|
| 1992 |
Bandara G, Robbins PD, Georgescu HI, Mueller GM, Glorioso JC, Evans CH. Gene transfer to synoviocytes: prospects for gene treatment of arthritis. Dna and Cell Biology. 11: 227-31. PMID 1567555 DOI: 10.1089/Dna.1992.11.227 |
0.38 |
|
| 1992 |
Dolter KE, Goins WF, Levine M, Glorioso JC. Genetic analysis of type-specific antigenic determinants of herpes simplex virus glycoprotein C. Journal of Virology. 66: 4864-73. PMID 1378512 DOI: 10.1128/Jvi.66.8.4864-4873.1992 |
0.337 |
|
| 1992 |
Sjöblom I, Glorioso JC, Sjögren-Jansson E, Olofsson S. Antigenic structure of the herpes simplex virus type 1 glycoprotein C: demonstration of a linear epitope situated in an environment of highly conformation-dependent epitopes. Apmis : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. 100: 229-36. PMID 1373286 DOI: 10.1111/J.1699-0463.1992.Tb00865.X |
0.376 |
|
| 1992 |
Gage PJ, Sauer B, Levine M, Glorioso JC. A cell-free recombination system for site-specific integration of multigenic shuttle plasmids into the herpes simplex virus type 1 genome. Journal of Virology. 66: 5509-15. PMID 1323709 DOI: 10.1128/Jvi.66.9.5509-5515.1992 |
0.485 |
|
| 1992 |
Fink DJ, Sternberg LR, Weber PC, Mata M, Goins WF, Glorioso JC. In vivo expression of beta-galactosidase in hippocampal neurons by HSV-mediated gene transfer. Human Gene Therapy. 3: 11-9. PMID 1314100 DOI: 10.1089/Hum.1992.3.1-11 |
0.505 |
|
| 1992 |
Glorioso JC, Sternberg LR, Goins WF, Fink DJ. Development of Herpes Simplex Virus as a Gene Transfer Vector for the Central Nervous System Gene Therapy. 133-145. DOI: 10.1007/978-3-642-84842-1_11 |
0.437 |
|
| 1991 |
Mester JC, Glorioso JC, Rouse BT. Protection against zosteriform spread of herpes simplex virus by monoclonal antibodies. The Journal of Infectious Diseases. 163: 263-9. PMID 1846388 DOI: 10.1093/Infdis/163.2.263 |
0.333 |
|
| 1991 |
Olofsson S, Sjöblom I, Glorioso JC, Jeansson S, Datema R. Selective induction of discrete epitopes of herpes simplex virus type 1-specified glycoprotein C by interference with terminal steps in glycosylation. The Journal of General Virology. 72: 1959-65. PMID 1714943 DOI: 10.1099/0022-1317-72-8-1959 |
0.378 |
|
| 1991 |
Hendricks RL, Weber PC, Taylor JL, Koumbis A, Tumpey TM, Glorioso JC. Endogenously produced interferon alpha protects mice from herpes simplex virus type 1 corneal disease. The Journal of General Virology. 72: 1601-10. PMID 1649898 DOI: 10.1099/0022-1317-72-7-1601 |
0.417 |
|
| 1991 |
Highlander SL, Goins WF, Person S, Holland TC, Levine M, Glorioso JC. Oligomer formation of the gB glycoprotein of herpes simplex virus type 1. Journal of Virology. 65: 4275-83. PMID 1649330 DOI: 10.1128/Jvi.65.8.4275-4283.1991 |
0.379 |
|
| 1990 |
Kimmel KA, Dolter KE, Toth GM, Levine M, Glorioso JC. Serologic type conversion of a herpes simplex virus type 1 (HSV-1) to an HSV-2 epitope caused by a single amino acid substitution in glycoprotein C. Journal of Virology. 64: 4033-6. PMID 2164613 DOI: 10.1128/Jvi.64.8.4033-4036.1990 |
0.376 |
|
| 1990 |
Kikuchi GE, Glorioso JC, Nairn R. Cross-linking studies show that herpes simplex virus type 1 glycoprotein C molecules are clustered in the membrane of infected cells. The Journal of General Virology. 71: 455-8. PMID 2155298 DOI: 10.1099/0022-1317-71-2-455 |
0.355 |
|
| 1990 |
Langeland N, Oyan AM, Marsden HS, Cross A, Glorioso JC, Moore LJ, Haarr L. Localization on the herpes simplex virus type 1 genome of a region encoding proteins involved in adsorption to the cellular receptor. Journal of Virology. 64: 1271-7. PMID 2154609 DOI: 10.1128/Jvi.64.3.1271-1277.1990 |
0.444 |
|
| 1990 |
Weber PC, Levine M, Glorioso JC. Recombinogenic properties of herpes simplex virus type 1 DNA sequences resident in simian virus 40 minichromosomes. Journal of Virology. 64: 300-6. PMID 2152818 DOI: 10.1128/Jvi.64.1.300-306.1990 |
0.411 |
|
| 1990 |
Levine M, Krikos A, Glorioso JC, Homa FL. Regulation of expression of the glycoprotein genes of herpes simplex virus type 1 (HSV-1). Advances in Experimental Medicine and Biology. 278: 151-64. PMID 1963032 DOI: 10.1007/978-1-4684-5853-4_16 |
0.458 |
|
| 1990 |
Mester JC, Highlander SL, Osmand AP, Glorioso JC, Rouse BT. Herpes simplex virus type 1-specific immunity induced by peptides corresponding to an antigenic site of glycoprotein B. Journal of Virology. 64: 5277-83. PMID 1698994 DOI: 10.1128/Jvi.64.11.5277-5283.1990 |
0.333 |
|
| 1989 |
Chrisp CE, Sunstrum JC, Averill DR, Levine M, Glorioso JC. Characterization of encephalitis in adult mice induced by intracerebral inoculation of herpes simplex virus type 1 (KOS) and comparison with mutants showing decreased virulence. Laboratory Investigation; a Journal of Technical Methods and Pathology. 60: 822-30. PMID 2543866 |
0.35 |
|
| 1988 |
Sunstrum JC, Chrisp CE, Levine M, Glorioso JC. Pathogenicity of glycoprotein C negative mutants of herpes simplex virus type 1 for the mouse central nervous system. Virus Research. 11: 17-32. PMID 2845681 DOI: 10.1016/0168-1702(88)90064-0 |
0.337 |
|
| 1988 |
Huff V, Cai W, Glorioso JC, Levine M. The carboxy-terminal 41 amino acids of herpes simplex virus type 1 glycoprotein B are not essential for production of infectious virus particles. Journal of Virology. 62: 4403-6. PMID 2845151 DOI: 10.1128/Jvi.62.11.4403-4406.1988 |
0.329 |
|
| 1988 |
Homa FL, Glorioso JC, Levine M. A specific 15-bp TATA box promoter element is required for expression of a herpes simplex virus type 1 late gene. Genes & Development. 2: 40-53. PMID 2833425 DOI: 10.1101/Gad.2.1.40 |
0.426 |
|
| 1987 |
Weise K, Kaerner HC, Glorioso J, Schröder CH. Replacement of glycoprotein B gene sequences in herpes simplex virus type 1 strain ANG by corresponding sequences of the strain KOS causes changes of plaque morphology and neuropathogenicity. Journal of General Virology. 68: 1909-1919. PMID 3037014 DOI: 10.1099/0022-1317-68-7-1909 |
0.388 |
|
| 1987 |
Weber PC, Levine M, Glorioso JC. Rapid identification of nonessential genes of herpes simplex virus type 1 by Tn5 mutagenesis. Science (New York, N.Y.). 236: 576-9. PMID 3033824 DOI: 10.1126/Science.3033824 |
0.391 |
|
| 1987 |
Shapira M, Homa FL, Glorioso JC, Levine M. Regulation of the herpes simplex virus type 1 late (gamma 2) glycoprotein C gene: sequences between base pairs -34 to +29 control transient expression and responsiveness to transactivation by the products of the immediate early (alpha) 4 and 0 genes. Nucleic Acids Research. 15: 3097-111. PMID 3031620 DOI: 10.1093/Nar/15.7.3097 |
0.334 |
|
| 1987 |
Kikuchi GE, Baker SA, Merajver SD, Coligan JE, Levine M, Glorioso JC, Nairn R. Purification and structural characterization of herpes simplex virus glycoprotein C. Biochemistry. 26: 424-31. PMID 3030409 DOI: 10.1021/Bi00376A013 |
0.311 |
|
| 1987 |
Sjöblom I, Lundström M, Sjögren-Jansson E, Glorioso JC, Jeansson S, Olofsson S. Demonstration and mapping of highly carbohydrate-dependent epitopes in the herpes simplex virus type 1-specified glycoprotein C. The Journal of General Virology. 68: 545-54. PMID 2434609 DOI: 10.1099/0022-1317-68-2-545 |
0.339 |
|
| 1986 |
Homa FL, Otal TM, Glorioso JC, Levine M. Transcriptional control signals of a herpes simplex virus type 1 late (gamma 2) gene lie within bases -34 to +124 relative to the 5' terminus of the mRNA. Molecular and Cellular Biology. 6: 3652-66. PMID 3025606 DOI: 10.1128/Mcb.6.11.3652 |
0.439 |
|
| 1986 |
Homa FL, Purifoy DJ, Glorioso JC, Levine M. Molecular basis of the glycoprotein C-negative phenotypes of herpes simplex virus type 1 mutants selected with a virus-neutralizing monoclonal antibody. Journal of Virology. 58: 281-9. PMID 3009845 DOI: 10.1128/Jvi.58.2.281-289.1986 |
0.391 |
|
| 1986 |
Johnson DC, McDermott MR, Chrisp C, Glorioso JC. Pathogenicity in mice of herpes simplex virus type 2 mutants unable to express glycoprotein C. Journal of Virology. 58: 36-42. PMID 3005656 |
0.336 |
|
| 1986 |
Marlin SD, Highlander SL, Holland TC, Levine M, Glorioso JC. Antigenic variation (mar mutations) in herpes simplex virus glycoprotein B can induce temperature-dependent alterations in gB processing and virus production. Journal of Virology. 59: 142-53. PMID 2423702 DOI: 10.1128/Jvi.59.1.142-153.1986 |
0.372 |
|
| 1985 |
Goldin AL, Sandri-Goldin RM, Glorioso JC, Levine M. Stable induction of a 51K cellular protein in neuronal cells surviving herpes simplex virus type 1 infection. Virology. 142: 398-405. PMID 2997992 DOI: 10.1016/0042-6822(85)90347-2 |
0.617 |
|
| 1985 |
Schröder CH, DeZazzo J, Knopf KW, Kaerner HC, Levine M, Glorioso J. A herpes simplex virus type 1 mutant with a deletion in the polypeptide-coding sequences of the ICP4 gene. The Journal of General Virology. 66: 1589-93. PMID 2991430 DOI: 10.1099/0022-1317-66-7-1589 |
0.398 |
|
| 1985 |
Marlin SD, Holland TC, Levine M, Glorioso JC. Epitopes of herpes simplex virus type 1 glycoprotein gC are clustered in two distinct antigenic sites. Journal of Virology. 53: 128-36. PMID 2578193 DOI: 10.1128/Jvi.53.1.128-136.1985 |
0.301 |
|
| 1985 |
Kümel G, Kaerner HC, Levine M, Schröder CH, Glorioso JC. Passive immune protection by herpes simplex virus-specific monoclonal antibodies and monoclonal antibody-resistant mutants altered in pathogenicity. Journal of Virology. 56: 930-7. PMID 2415719 DOI: 10.1128/Jvi.56.3.930-937.1985 |
0.364 |
|
| 1984 |
Glorioso J, Schröder CH, Kumel G, Szczesiul M, Levine M. Immunogenicity of herpes simplex virus glycoproteins gC and gB and their role in protective immunity. Journal of Virology. 50: 805-12. PMID 6328010 DOI: 10.1128/Jvi.50.3.805-812.1984 |
0.441 |
|
| 1984 |
Sandri-Goldin RM, Goldin AL, Glorioso J, Levine M. Herpes simplex virus thymidine kinase gene is stably maintained and expressed in cells transformed by protoplast fusion. Somatic Cell and Molecular Genetics. 10: 129-38. PMID 6324392 DOI: 10.1007/Bf01534902 |
0.616 |
|
| 1984 |
Holland LE, Sandri-Goldin RM, Goldin AL, Glorioso JC, Levine M. Transcriptional and genetic analyses of the herpes simplex virus type 1 genome: coordinates 0.29 to 0.45. Journal of Virology. 49: 947-59. PMID 6199514 DOI: 10.1128/Jvi.49.3.947-959.1984 |
0.621 |
|
| 1984 |
Kikuchi GE, Coligan JE, Holland TC, Levine M, Glorioso JC, Nairn R. Biochemical characterization of peptides from herpes simplex virus glycoprotein gC: loss of CNBr fragments from the carboxy terminus of truncated, secreted gC molecules. Journal of Virology. 52: 806-15. PMID 6092712 DOI: 10.1128/Jvi.52.3.806-815.1984 |
0.317 |
|
| 1984 |
Holland TC, Homa FL, Marlin SD, Levine M, Glorioso J. Herpes simplex virus type 1 glycoprotein C-negative mutants exhibit multiple phenotypes, including secretion of truncated glycoproteins. Journal of Virology. 52: 566-74. PMID 6092678 DOI: 10.1128/Jvi.52.2.566-574.1984 |
0.331 |
|
| 1983 |
Sandri-Goldin RM, Goldin AL, Levine M, Glorioso J. High-efficiency transfer of DNA into eukaryotic cells by protoplast fusion. Methods in Enzymology. 101: 402-11. PMID 6350818 DOI: 10.1016/0076-6879(83)01030-7 |
0.649 |
|
| 1983 |
Sandri-Goldin RM, Goldin AL, Holland LE, Glorioso JC, Levine M. Expression of herpes simplex virus beta and gamma genes integrated in mammalian cells and their induction by an alpha gene product. Molecular and Cellular Biology. 3: 2028-44. PMID 6318078 DOI: 10.1128/Mcb.3.11.2028 |
0.672 |
|
| 1983 |
Holland TC, Sandri-Goldin RM, Holland LE, Marlin SD, Levine M, Glorioso JC. Physical mapping of the mutation in an antigenic variant of herpes simplex virus type 1 by use of an immunoreactive plaque assay. Journal of Virology. 46: 649-52. PMID 6302327 DOI: 10.1128/Jvi.46.2.649-652.1983 |
0.388 |
|
| 1981 |
Sandri-Goldin RM, Goldin AL, Levine M, Glorioso JC. High-frequency transfer of cloned herpes simplex virus type 1 sequences to mammalian cells by protoplast fusion. Molecular and Cellular Biology. 1: 743-52. PMID 9279387 DOI: 10.1128/Mcb.1.8.743 |
0.656 |
|
| 1981 |
Goldin AL, Sandri-Goldin RM, Levine M, Glorioso JC. Cloning of herpes simplex virus type 1 sequences representing the whole genome. Journal of Virology. 38: 50-8. PMID 6264114 DOI: 10.1128/Jvi.38.1.50-58.1981 |
0.631 |
|
| 1981 |
Sandri-Goldin RM, Levine M, Glorioso JC. Method for induction of mutations in physically defined regions of the herpes simplex virus genome. Journal of Virology. 38: 41-9. PMID 6264113 DOI: 10.1128/Jvi.38.1.41-49.1981 |
0.367 |
|
| 1980 |
Glorioso JC, Levine M, Holland TC, Szczesiul MS. Mutant analysis of herpes simplex virus-induced cell surface antigens: resistance to complement-mediated immune cytolysis. Journal of Virology. 35: 672-81. PMID 6252331 DOI: 10.1128/Jvi.35.3.672-681.1980 |
0.384 |
|
| 1980 |
Levine M, Goldin AL, Glorioso JC. Persistence of herpes simplex virus genes in cells of neuronal origin. Journal of Virology. 35: 203-10. PMID 6251268 DOI: 10.1128/Jvi.35.1.203-210.1980 |
0.685 |
|
| 1978 |
Glorioso JC, Wilson LA, Fenger TW, Smith JW. Complement-mediated cytolysis of HSV-1 and HSV-2 infected cells: plasma membrane antigens reactive with type-specific and cross-reactive antibody. The Journal of General Virology. 40: 443-54. PMID 211189 DOI: 10.1099/0022-1317-40-2-443 |
0.33 |
|
| 1978 |
Adler R, Glorioso JC, Levine M. Infection by herpes simplex virus and cells of nervous system origin: characterization of a non-permissive interaction. The Journal of General Virology. 39: 9-20. PMID 205630 DOI: 10.1099/0022-1317-39-1-9 |
0.447 |
|
| Show low-probability matches. |